ಕಡಿಮೆ ಪ್ರೇರಣೆಯು ಮಾನಸಿಕ-ಆರೋಗ್ಯದ ಲಕ್ಷಣ, ಅಸ್ತವ್ಯಸ್ತವಾಗಿರುವ ನಿದ್ರೆ ಅಥವಾ ಒತ್ತಡದ ಸಂಕೇತ, ಅಥವಾ ಹಿಂತಿರುಗಿಸಬಹುದಾದ ವೈದ್ಯಕೀಯ ಸಮಸ್ಯೆಗೆ ಸುಳಿವಾಗಬಹುದು. ರೋಗಲಕ್ಷಣಗಳು, ಔಷಧಿಗಳು ಮತ್ತು ಆಯ್ದ ಪ್ರಯೋಗಾಲಯ ಫಲಿತಾಂಶಗಳ ಕೇಂದ್ರೀಕೃತ ವಿಮರ್ಶೆಯು ಆ ಸಾಧ್ಯತೆಗಳನ್ನು ಬೇರ್ಪಡಿಸಲು ಸಹಾಯ ಮಾಡುತ್ತದೆ.
- ಪ್ರಥಮ-ಸಾಲಿನ ಪ್ಯಾನೆಲ್ 2-4 ವಾರಗಳವರೆಗೆ ಕಡಿಮೆ ಪ್ರೇರಣೆ ಮುಂದುವರಿದರೆ, ಸಾಮಾನ್ಯವಾಗಿ CBC, ಫೆರಿಟಿನ್, TSH, ಫ್ರೀ T4, ವಿಟಮಿನ್ B12, HbA1c, ಮೂತ್ರಪಿಂಡದ ಕಾರ್ಯ ಮತ್ತು ಯಕೃತ್ತಿನ ಕಿಣ್ವಗಳನ್ನು ಒಳಗೊಂಡಿರುತ್ತದೆ.
- ಫೆರಿಟಿನ್ 30 ng/mL ಕ್ಕಿಂತ ಕಡಿಮೆ ಸಾಮಾನ್ಯವಾಗಿ ಹಿಮೋಗ್ಲೋಬಿನ್ ಸಾಮಾನ್ಯವಾಗಿದ್ದರೂ ಸಹ, ಉತ್ತಮ ವಯಸ್ಕರಲ್ಲಿ ಕಬ್ಬಿಣದ ಸಂಗ್ರಹದ ಕೊರತೆಯನ್ನು ಸೂಚಿಸುತ್ತದೆ.
- TSH 10 mIU/L ಕ್ಕಿಂತ ಹೆಚ್ಚಾಗಿದೆ ಕಡಿಮೆ ಫ್ರೀ T4 ಯೊಂದಿಗೆ ಸ್ಪಷ್ಟ ಹೈಪೋಥೈರಾಯಡಿಸಂ ಅನ್ನು ಬಲವಾಗಿ ಬೆಂಬಲಿಸುತ್ತದೆ ಮತ್ತು ವೈದ್ಯಕೀಯ-ಚಾಲಿತ ಚಿಕಿತ್ಸೆಯ ಅಗತ್ಯವಿದೆ.
- 200 pg/mL ಕ್ಕಿಂತ ಕಡಿಮೆ ವಿಟಮಿನ್ B12 ಸಾಮಾನ್ಯವಾಗಿ ಕೊರತೆಯೆಂದು ಪರಿಗಣಿಸಲಾಗುತ್ತದೆ; 200-350 pg/mL ಒಂದು ಬೂದು ವಲಯವಾಗಿದ್ದು, ಅಲ್ಲಿ ಮಿಥೈಲ್ಮಲೋನಿಕ್ ಆಮ್ಲವು ಅಂಗಾಂಶದ ಕೊರತೆಯನ್ನು ಸ್ಪಷ್ಟಪಡಿಸಬಹುದು.
- HbA1c 5.7-6.4% ಪ್ರಿಡಯಾಬಿಟಿಸ್ ಅನ್ನು ಸೂಚಿಸುತ್ತದೆ, ಆದರೆ ಹೆಚ್ಚಿನ ಗರ್ಭಿಣಿಯಲ್ಲದ ವಯಸ್ಕರಲ್ಲಿ ದೃಢೀಕರಣ ಪರೀಕ್ಷೆಯಲ್ಲಿ 6.5% ಅಥವಾ ಅದಕ್ಕಿಂತ ಹೆಚ್ಚಿನದು ಮಧುಮೇಹವನ್ನು ಬೆಂಬಲಿಸುತ್ತದೆ.
- ನಿದ್ರೆಯ ನಷ್ಟವು ಲ್ಯಾಬ್‌ಗಳನ್ನು ಬದಲಾಯಿಸುತ್ತದೆ: ಒಂದು ಕೆಟ್ಟ ರಾತ್ರಿಯು ಪ್ರತಿ ರೋಗಲಕ್ಷಣವನ್ನು ವಿವರಿಸದೆಯೇ ಉಪವಾಸ ಗ್ಲೂಕೋಸ್, ಕಾರ್ಟಿಸೋಲ್ ಮತ್ತು ಉರಿಯೂತದ ಮಾರ್ಕರ್‌ಗಳನ್ನು ಹೆಚ್ಚಿಸಬಹುದು.
- ಔಷಧಿಗಳ ವಿಮರ್ಶೆಯು ಮುಖ್ಯವಾಗಿದೆ ಏಕೆಂದರೆ ನಿದ್ರಾಜನಕ ಆಂಟಿಹಿಸ್ಟಮೈನ್ಗಳು, ಓಪಿಯಾಟ್‌ಗಳು, ಬೆಂಜೊಡಿಯಜೆಪೈನ್ಗಳು, ಕೆಲವು ಆಂಟಿಸೀಜರ್ ಔಷಧಿಗಳು ಮತ್ತು ಬೀಟಾ-ಬ್ಲಾಕರ್ಗಳು ಅಸಹಜ ದಿನನಿತ್ಯದ ರಕ್ತದ ಫಲಿತಾಂಶವನ್ನು ಉಂಟುಮಾಡದೆ ಚಾಲನೆಯನ್ನು ಮಂದಗೊಳಿಸಬಹುದು.
- ತುರ್ತು ಸಹಾಯ ಬೇಕು ಆತ್ಮಹತ್ಯೆಯ ಆಲೋಚನೆಗಳು, ಆಹಾರ ಅಥವಾ ದ್ರವವನ್ನು ಉಳಿಸಿಕೊಳ್ಳಲು ಅಸಮರ್ಥತೆ, ಗೊಂದಲ, ತೀವ್ರ ದೌರ್ಬಲ್ಯ, ಎದೆ ನೋವು, ಅಥವಾ ವೇಗವಾಗಿ ಹದಗೆಡುತ್ತಿರುವ ಲಕ್ಷಣಗಳಿಗಾಗಿ.
ಕಡಿಮೆ ಪ್ರೇರಣೆಗಾಗಿ ರಕ್ತ ಪರೀಕ್ಷೆಯು ನಿಜವಾಗಿ ಏನು ತೋರಿಸಬಹುದು
A ಕಡಿಮೆ ಪ್ರೇರಣೆಗಾಗಿ ರಕ್ತ ಪರೀಕ್ಷೆ ಕಬ್ಬಿಣದ ಕೊರತೆ, ಥೈராய್ಡ್ ಕಾಯಿಲೆ, B12 ಕೊರತೆ, ಮಧುಮೇಹ, ಮೂತ್ರಪಿಂಡ ಅಥವಾ ಯಕೃತ್ತಿನ ಅಸಮರ್ಪಕ ಕಾರ್ಯದಂತಹ ಹಿಮ್ಮುಖಗೊಳಿಸಬಹುದಾದ ಅಂಶಗಳನ್ನು ಗುರುತಿಸಬಹುದು, ಆದರೆ ಇದು ಖಿನ್ನತೆ, ADHD, ಸುಸ್ತಾಗುವಿಕೆ ಅಥವಾ ದುಃಖವನ್ನು ತನ್ನದೇ ಆದ ಮೇಲೆ ರೋಗನಿರ್ಣಯ ಮಾಡಲು ಸಾಧ್ಯವಿಲ್ಲ. ಮಾನಸಿಕ-ಆರೋಗ್ಯ ಮತ್ತು ಔಷಧೀಯ ಮೌಲ್ಯಮಾಪನದ ಜೊತೆಗೆ, ವಿಶೇಷವಾಗಿ ಲಕ್ಷಣಗಳು 2-4 ವಾರಗಳಿಗಿಂತ ಹೆಚ್ಚು ಕಾಲ ಇದ್ದಾಗ, ಗುರಿಯನ್ನು ಹೊಂದಿರುವ ಪರೀಕ್ಷೆಯು ಉಪಯುಕ್ತ ವಿಧಾನವಾಗಿದೆ.
ನನ್ನ ಕ್ಲಿನಿಕಲ್ ಕೆಲಸದಲ್ಲಿ, ನಾನು ಮೊದಲು ಮಾಡುವ ವ್ಯತ್ಯಾಸವೆಂದರೆ ಕಡಿಮೆಯಾದ ಶಕ್ತಿ, ಕಡಿಮೆಯಾದ ಸಂತೋಷ ಮತ್ತು ಕಡಿಮೆಯಾದ ಉಪಕ್ರಮ. ಏನನ್ನಾದರೂ ಮಾಡಲು ಬಯಸುವ ಆದರೆ ಪ್ರಾರಂಭಿಸಲು ಸಾಧ್ಯವಾಗದ ವ್ಯಕ್ತಿಯು ನಿದ್ರೆಯ ಋಣ, ಖಿನ್ನತೆ, ಕಾರ್ಯನಿರ್ವಾಹಕ-ಕಾರ್ಯದ ಅಸಮರ್ಪಕತೆ, ಔಷಧೀಯ ನಿದ್ರಾಹೀನತೆ ಅಥವಾ ಕಬ್ಬಿಣದ ಕೊರತೆಯನ್ನು ಹೊಂದಿರಬಹುದು; ಲ್ಯಾಬ್ ಫಲಿತಾಂಶವು ಅಪರೂಪವಾಗಿ ಅದನ್ನು ಪರಿಹರಿಸುತ್ತದೆ. ಡಾ. ಥಾಮಸ್ ಕ್ಲೈನ್ ಪರೀಕ್ಷಿಸುವ ಮೊದಲು ಆರಂಭದ ದಿನಾಂಕ, ನಿದ್ರೆಯ ಅವಧಿ ಮತ್ತು ಪ್ರತಿ ಪ್ರಿಸ್ಕ್ರಿಪ್ಷನ್, ಪೂರಕ ಮತ್ತು ಮನರಂಜನಾ ವಸ್ತುವನ್ನು ದಾಖಲಿಸಲು ಶಿಫಾರಸು ಮಾಡುತ್ತಾರೆ.
Kantesti ಒಂದು AI ರಕ್ತ ಪರೀಕ್ಷಾ ವಿಶ್ಲೇಷಕ ಇದು ಫೆರಿಟಿನ್, ಥೈರಾಯ್ಡ್, B12, ಗ್ಲೂಕೋಸ್ ಮತ್ತು ರಕ್ತ-ಎಣಿಕೆಯ ಮಾದರಿಗಳನ್ನು ಒಟ್ಟಿಗೆ ವ್ಯಾಖ್ಯಾನಿಸುತ್ತದೆ, ಒಂದೇ ಧ್ವಜದ ಮೌಲ್ಯವನ್ನು ರೋಗನಿರ್ಣಯವಾಗಿ ಪರಿಗಣಿಸುವುದಕ್ಕಿಂತ. ನಮ್ಮ ಬಯೋಮಾರ್ಕರ್ ಮಾರ್ಗದರ್ಶಿಯಲ್ಲಿ ನಿಮ್ಮ ವರದಿಯು ಅಪರಿಚಿತ ಘಟಕಗಳನ್ನು ಅಥವಾ ಪ್ರಯೋಗಾಲಯ-ನಿರ್ದಿಷ್ಟ ವ್ಯಾಪ್ತಿಯನ್ನು ಬಳಸಿದಾಗ ಉಪಯುಕ್ತವಾಗಿದೆ.
ಸಾಮಾನ್ಯ ಸ್ಕ್ರೀನಿಂಗ್ ಕಥೆಗೆ ಅನುಪಾತದಲ್ಲಿರಬೇಕು. ಭಾರೀ ಋತುಸ್ರಾವ, ಅಶಾಂತ ಕಾಲುಗಳು ಮತ್ತು ಜಿಮ್ ಕಾರ್ಯಕ್ಷಮತೆಯ ಕುಸಿತವನ್ನು ಹೊಂದಿರುವ 26-ವರ್ಷ ವಯಸ್ಸಿನ ವ್ಯಕ್ತಿಯು 58-ವರ್ಷ ವಯಸ್ಸಿನ ವ್ಯಕ್ತಿಯಿಂದ ಭಿನ್ನವಾದ ಕೆಲಸವನ್ನು ಹೊಂದಿದ್ದಾನೆ, ಅವರ ಪ್ರೇರಣೆಯು ಬೀಟಾ-ಬ್ಲಾಕರ್ ಪ್ರಾರಂಭಿಸಿದ ನಂತರ ಬದಲಾಯಿತು. ಫಲಿತಾಂಶಗಳು ವೈದ್ಯರೊಂದಿಗೆ ಪರಿಶೀಲಿಸಲು ಸುಳಿವುಗಳಾಗಿವೆ, ಪ್ರತಿ ಭಾವನಾತ್ಮಕ ಲಕ್ಷಣವು ಜೈವಿಕ ರಾಸಾಯನಿಕ ಕಾರಣವನ್ನು ಹೊಂದಿದೆ ಎಂಬುದಕ್ಕೆ ಪುರಾವೆಯಲ್ಲ.
ರೋಗಲಕ್ಷಣದ ಮಾದರಿ ಮತ್ತು ಸಮಯದೊಂದಿಗೆ ಪ್ರಾರಂಭಿಸಿ
ಕಡಿಮೆ ಪ್ರೇರಣೆಯ ಸಮಯವು ಯಾವ ಪರೀಕ್ಷೆಗಳು ಯೋಗ್ಯವಾಗಿವೆ ಎಂಬುದನ್ನು ಊಹಿಸುತ್ತದೆ: ದಿನಗಳಲ್ಲಿ ದಿಢೀರ್ ಲಕ್ಷಣಗಳು ಅನಾರೋಗ್ಯ, ನಿದ್ರೆ, ಪದಾರ್ಥಗಳು ಮತ್ತು ಔಷಧದ ಬದಲಾವಣೆಗಳ ಬಗ್ಗೆ ಪ್ರಶ್ನೆಗಳನ್ನು ಎತ್ತುತ್ತವೆ, ಆದರೆ ತಿಂಗಳುಗಳವರೆಗೆ ನಿಧಾನಗತಿಯ ಕುಸಿತವು ಪೋಷಕಾಂಶ, ಥೈರಾಯ್ಡ್ ಮತ್ತು ಚಯಾಪಚಯ ಪರೀಕ್ಷೆಗಳನ್ನು ಹೆಚ್ಚು ಬಾರಿ ಸಮರ್ಥಿಸುತ್ತದೆ. ಸ್ಪಷ್ಟ ಸಮಯರೇಖೆಯು ವಿಶಾಲವಾದ ಕಡಿಮೆ-ಮೌಲ್ಯದ ಪರೀಕ್ಷೆಯನ್ನು ತಡೆಯುತ್ತದೆ.
ವೈರಲ್ ಅನಾರೋಗ್ಯ, ಶಸ್ತ್ರಚಿಕಿತ್ಸೆ, ಹೊಸ ಆಹಾರ ಅಥವಾ ಪ್ರಮುಖ ಜೀವನ ಘಟನೆಯ ನಂತರ ಪ್ರಾರಂಭವಾಗುವ ಕಡಿಮೆ ಪ್ರೇರಣೆಯು ಅನೇಕ ಪರೀಕ್ಷೆಗಳ ಪಟ್ಟಿಗಿಂತ ಮೊದಲು ಸಮಯರೇಖೆಯನ್ನು ಅರ್ಹತೆ ಪಡೆಯುತ್ತದೆ. CBC, ಫೆರಿಟಿನ್, TSH, ಕ್ರಿಯೇಟಿನೈನ್, ಎಲೆಕ್ಟ್ರೋಲೈಟ್ಸ್, ALT ಮತ್ತು HbA1c ಒಂದು ಒಪ್ಪತಕ್ಕಾದ ಮೊದಲ ಪ್ರಯತ್ನದಲ್ಲಿ ಹಲವಾರು ಸಾಮಾನ್ಯ ದೈಹಿಕ ಕೊಡುಗೆಗಳನ್ನು ಒಳಗೊಂಡಿವೆ. ದಿ ಪೂರ್ಣ ರಕ್ತದ ಎಣಿಕೆ ಮಾರ್ಗದರ್ಶಿ ಹಿಮೋಗ್ಲೋಬಿನ್, MCV ಮತ್ತು ಬಿಳಿ-ಕೋಶ ಮಾದರಿಗಳು ಒಟ್ಟಿಗೆ ಏಕೆ ಮುಖ್ಯವೆಂದು ವಿವರಿಸುತ್ತದೆ.
4-5 ಗಂಟೆಗಳ ನಿದ್ರೆಯ ಮೂರು ರಾತ್ರಿಗಳ ನಂತರ ಪರೀಕ್ಷಿಸಿದ ವ್ಯಕ್ತಿಗಳಲ್ಲಿ ನಾನು ಪುನರಾವರ್ತಿತ ಬಲೆಯನ್ನು ನೋಡುತ್ತೇನೆ: ಅವರು ಸ್ವಲ್ಪ ಹೆಚ್ಚಿನ ಗ್ಲೂಕೋಸ್ ಅಥವಾ ಕಡಿಮೆ-ಸಾಮಾನ್ಯ T3 ಎಲ್ಲವನ್ನೂ ವಿವರಿಸುತ್ತದೆ ಎಂದು ಊಹಿಸುತ್ತಾರೆ. ಇದು ತಾತ್ಕಾಲಿಕ ಶರೀರಶಾಸ್ತ್ರವನ್ನು ಪ್ರತಿಬಿಂಬಿಸಬಹುದು, ವಿಶೇಷವಾಗಿ ತೀವ್ರ ವ್ಯಾಯಾಮ, ಉಪವಾಸ ಅಥವಾ ತೀವ್ರ ಅನಾರೋಗ್ಯದ ನಂತರ ಡ್ರಾದಲ್ಲಿ. ಸಾಮಾನ್ಯ ಪರಿಸ್ಥಿತಿಗಳಲ್ಲಿ ಪುನರಾವರ್ತನೆಯು ಗಡಿರೇಖೆಯ ಸಂಖ್ಯೆಯನ್ನು ಬೆನ್ನಟ್ಟುವುದು ಹೆಚ್ಚು ಮಾಹಿತಿಯುಕ್ತವಾಗಿರುತ್ತದೆ.
ಆಗಸ್ಟ್ 25, 2026 ರಂತೆ, ಯಾವುದೇ ಪ್ರಮುಖ ಮಾರ್ಗಸೂಚಿಗಳು ಕಡಿಮೆ ಪ್ರೇರಣೆಯ ಸ್ವಂತಕ್ಕೆ ಸಾಮಾನ್ಯ ಸ್ಕ್ರೀನಿಂಗ್ ಆಗಿ ವಿಶಾಲವಾದ ಹಾರ್ಮೋನ್ ಪ್ಯಾನೆಲ್ ಅಥವಾ ಕಾರ್ಟಿಸೋಲ್ ಪರೀಕ್ಷೆಯನ್ನು ಶಿಫಾರಸು ಮಾಡುವುದಿಲ್ಲ. ತೂಕದಲ್ಲಿನ ಬದಲಾವಣೆ, ಮಲಬದ್ಧತೆ, ಶೀತದ ಅಸಹಿಷ್ಣುತೆ, ಮರಗಟ್ಟುವಿಕೆ, ಭಾರೀ ಋತುಸ್ರಾವದ ನಷ್ಟ, ಬಾಯಾರಿಕೆ, ಗೊರಕೆ ಅಥವಾ ಔಷಧದ ಮಾನ್ಯತೆ ಇದ್ದಲ್ಲಿ ದೈಹಿಕ ಸುಳಿವುಗಳಿದ್ದಾಗ ಪರೀಕ್ಷೆಯು ಹೆಚ್ಚು ನಿರ್ದಿಷ್ಟವಾಗುತ್ತದೆ.
ರಕ್ತಹೀನತೆ ಕಾಣಿಸಿಕೊಳ್ಳುವ ಮೊದಲು ಕಬ್ಬಿಣದ ಕೊರತೆಯು ಸಹಿಷ್ಣುತೆಯನ್ನು ಕಡಿಮೆ ಮಾಡಬಹುದು
ಫೆರಿಟಿನ್ 30 ng/mL ಕ್ಕಿಂತ ಕಡಿಮೆ ಸಾಮಾನ್ಯವಾಗಿ ಸಕ್ರಿಯ ಉರಿಯೂತವಿಲ್ಲದ ವಯಸ್ಕರಲ್ಲಿ ಕಬ್ಬಿಣದ ಕೊರತೆಯನ್ನು ಸೂಚಿಸುತ್ತದೆ, ಮತ್ತು ಕಬ್ಬಿಣದ ಕೊರತೆಯು ಸಾಮಾನ್ಯ ಹಿಮೋಗ್ಲೋಬಿನ್ ಜೊತೆಗೂಡಿರಬಹುದು. ಕಡಿಮೆ ಕಬ್ಬಿಣದ ಸಂಗ್ರಹಗಳು ವಿಶೇಷವಾಗಿ ಸಂಭವನೀಯವಾಗಿವೆ, ಕಡಿಮೆ ಪ್ರೇರಣೆಯು ಶ್ರಮದಾಯಕ ಆಯಾಸ, ಕೂದಲು ಉದುರುವುದು, ಅಶಾಂತ ಕಾಲುಗಳು, ಉಬ್ಬಸ ಅಥವಾ ಭಾರೀ ಋತುಸ್ರಾವದೊಂದಿಗೆ ಕಂಡುಬರುತ್ತದೆ.
ಫೆರಿಟಿನ್ ಒಂದು ಕಬ್ಬಿಣ-ಸಂಗ್ರಹ ಪ್ರೋಟೀನ್ ಆಗಿದೆ, ಆದರೆ ಟ್ರಾನ್ಸ್‌ಫೆರಿನ್ ಸ್ಯಾಚುರೇಶನ್ ಅಂಗಾಂಶಗಳಿಗೆ ಲಭ್ಯವಿರುವ ರಕ್ತದ ಕಬ್ಬಿಣವನ್ನು ಅಂದಾಜಿಸುತ್ತದೆ. 20% ಗಿಂತ ಕಡಿಮೆ ಟ್ರಾನ್ಸ್‌ಫೆರಿನ್ ಸ್ಯಾಚುರೇಶನ್ ಕಬ್ಬಿಣದ ಲಭ್ಯತೆಯ ನಿರ್ಬಂಧವನ್ನು ಬೆಂಬಲಿಸುತ್ತದೆ; ಸೋಂಕು ಅಥವಾ ದೀರ್ಘಕಾಲದ ಉರಿಯೂತದ ಕಾಯಿಲೆಯ ಸಮಯದಲ್ಲಿ ಫೆರಿಟಿನ್ ಸುಳ್ಳು ಭರವಸೆ ನೀಡಬಹುದು ಏಕೆಂದರೆ ಇದು ತೀವ್ರ-ಹಂತದ ಪ್ರತಿಕ್ರಿಯೆಯಾಗಿ ಏರುತ್ತದೆ. ನಮ್ಮ ಐರನ್ ಅಧ್ಯಯನಗಳ ಉಲ್ಲೇಖ ಫೆರಿಟಿನ್, ಕಬ್ಬಿಣ, TIBC ಮತ್ತು ಸ್ಯಾಚುರೇಶನ್‌ನ ಉಪಯುಕ್ತ ಸಂಯೋಜನೆಯನ್ನು ವಿವರಿಸುತ್ತದೆ.
ನಾನು ಫೆರಿಟಿನ್ 14 ng/mL, ಹಿಮೋಗ್ಲೋಬಿನ್ 13.1 g/dL ಮತ್ತು MCV 86 fL ನೊಂದಿಗೆ ಪ್ಯಾನೆಲ್ ಅನ್ನು ಪರಿಶೀಲಿಸಿದಾಗ, ನಾನು CBC ಯನ್ನು ಸಾಮಾನ್ಯವೆಂದು ಕರೆದು ಮುಂದೆ ಸಾಗುವುದಿಲ್ಲ. ರೋಗಿಯು ಇನ್ನೂ ರಕ್ತಹೀನನಾಗಿರದಿರಬಹುದು, ಆದರೆ ಮಾದರಿಯು ಇನ್ನೂ ಕೊರತೆಯ ಸಂಗ್ರಹಕ್ಕೆ ಹೊಂದಿಕೆಯಾಗಬಹುದು, ವಿಶೇಷವಾಗಿ ಆಗಾಗ್ಗೆ ರಕ್ತದ ದಾನ ಅಥವಾ ದೀರ್ಘಕಾಲದ ಭಾರೀ ಋತುಸ್ರಾವದ ನಂತರ. ಕಾರಣಗಳನ್ನು ತನಿಖೆ ಮಾಡಬೇಕಾಗಿದೆ; ಅಸ್ಪಷ್ಟ ಜಠರಗರುಳಿನ ನಷ್ಟವನ್ನು ಮರೆಮಾಡಲು ಕಬ್ಬಿಣದ ಮಾತ್ರೆಗಳನ್ನು ಬಳಸಬಾರದು.
Kantesti ಒಂದು AI ರಕ್ತ ಪರೀಕ್ಷೆ ವರದಿ ಅರ್ಥ ಪ್ಲಾಟ್‌ಫಾರ್ಮ್ ಇದು ಫೆರಿಟಿನ್ ಜೊತೆಗೆ CRP, ಹಿಮೋಗ್ಲೋಬಿನ್, MCV ಮತ್ತು ಟ್ರಾನ್ಸ್‌ಫೆರಿನ್ ಸ್ಯಾಚುರೇಶನ್ ಅನ್ನು ಓದುತ್ತದೆ, ಇದು ಉರಿಯೂತವು ಫೆರಿಟಿನ್ ಅನ್ನು ಏಕೆ ತಿರುಚಬಹುದು ಎಂಬುದನ್ನು ಫ್ಲ್ಯಾಷ್ ಮಾಡಲು ಸಹಾಯ ಮಾಡುತ್ತದೆ. ನಿರಂತರ ಕಡಿಮೆ ಫೆರಿಟಿನ್ ಮತ್ತು ಸ್ಪಷ್ಟವಾದ ಋತುಸ್ರಾವ, ಆಹಾರ ಅಥವಾ ದಾನದ ವಿವರಣೆಯಿಲ್ಲದ ಜನರಿಗೆ celiac ಸ್ಕ್ರೀನಿಂಗ್ ಮತ್ತು ವಯಸ್ಸಿಗೆ-ಸೂಕ್ತವಾದ ಜಠರಗರುಳಿನ ಮೌಲ್ಯಮಾಪನದ ಬಗ್ಗೆ ಕೇಳಬೇಕು.
ಕಡಿಮೆ ಚಾಲನೆಯನ್ನು ಅನುಕರಿಸಬಲ್ಲ ಥೈರಾಯ್ಡ್ ಫಲಿತಾಂಶಗಳು
ಕಡಿಮೆ ಉಚಿತ T4 ಜೊತೆಗೆ ಹೆಚ್ಚಿನ TSH ಅತಿಯಾದ ಹೈಪೋಥೈರಾಯಡಿಸಂ ಅನ್ನು ಬೆಂಬಲಿಸುತ್ತದೆ ಮತ್ತು ನಿಧಾನಗತಿಯ ಚಿಂತನೆ, ಕಡಿಮೆ ಮನಸ್ಥಿತಿ, ಆಯಾಸ ಮತ್ತು ಕಡಿಮೆಯಾದ ಉಪಕ್ರಮಕ್ಕೆ ಕೊಡುಗೆ ನೀಡಬಹುದು. ಹೆಚ್ಚಿನ ಪ್ರಯೋಗಾಲಯಗಳಲ್ಲಿ, TSH ಸುಮಾರು 0.4-4.0 mIU/L ಆಗಿದೆ, ಆದರೆ ಪ್ರತಿ ವರದಿಯ ಅಂತರ ಮತ್ತು ಉಚಿತ T4 ಫಲಿತಾಂಶವು ಒಂದೇ ಸಾರ್ವತ್ರಿಕ ಕಟ್ಆಫ್‌ಗಿಂತ ಹೆಚ್ಚು ಮುಖ್ಯವಾಗಿರುತ್ತದೆ.
10 mIU/L ಗಿಂತ ಹೆಚ್ಚಿನ TSH, ವಿಶೇಷವಾಗಿ ಉಚಿತ T4 ವ್ಯಾಪ್ತಿಯ ಕೆಳಗೆ ಇದ್ದರೆ, ಸೌಮ್ಯವಾದ ಪ್ರತ್ಯೇಕ ಏರಿಕೆಯಕಿಂತ ಹೆಚ್ಚು ಕಾಳಜಿಯಾಗಿದೆ. NICE ಥೈರಾಯ್ಡ್ ಮಾರ್ಗದರ್ಶನವು ನಿರಂತರ ಉಪ-ಕ್ಲಿನಿಕಲ್ ಅಸಾಮಾನ್ಯತೆಗಳನ್ನು ದೃಢೀಕರಿಸಲು ಮತ್ತು ರೋಗಲಕ್ಷಣಗಳು, ಪ್ರತಿಕಾಯಗಳು, ವಯಸ್ಸು ಮತ್ತು ಹೃದಯ ಸಂಬಂಧಿ ಅಪಾಯವನ್ನು ಸ್ವಯಂಚಾಲಿತವಾಗಿ ಒಂದು ಗಡಿರೇಖೆಯ TSH ಫಲಿತಾಂಶವನ್ನು ಪರಿಗಣಿಸಲು ಸಲಹೆ ನೀಡುತ್ತದೆ (NICE, 2019, ನವೀಕರಿಸಲಾಗಿದೆ 2023). ಬയോಟಿನ್ ಪೂರಕಗಳು ಕೆಲವು ಇಮ್ಯುನೊಅಸ್ಸೇಗಳಿಗೆ ಅಡ್ಡಿಪಡಿಸಬಹುದು, ಆದ್ದರಿಂದ ಅಧಿಕ-ಡೋಸ್ ಕೂದಲು ಮತ್ತು ಉಗುರು ಉತ್ಪನ್ನಗಳ ಬಳಕೆಯನ್ನು ವರದಿ ಮಾಡಿ.
ಸಾಮಾನ್ಯ TSH ನಿಯಮಿತ ಕಡಿಮೆ ಪ್ರೇರಣೆಗೆ ರಿವರ್ಸ್ T3 ಅನ್ನು ಅಳೆಯಲು ಸಮರ್ಥಿಸುವುದಿಲ್ಲ; ಆ ಪರೀಕ್ಷೆಯು ವಿಶೇಷ ಸೆಟ್ಟಿಂಗ್‌ಗಳ ಹೊರಗೆ ನಿರ್ವಹಣೆಯನ್ನು ಅಪರೂಪವಾಗಿ ಬದಲಾಯಿಸುತ್ತದೆ. ಹೆಚ್ಚಿನ TSH ಇಲ್ಲದೆ ಕಡಿಮೆ ಉಚಿತ T4 ಅಸಾಮಾನ್ಯವಾಗಿದ್ದರೂ, ಕ್ಲಿನಿಕಲ್ ವಿಮರ್ಶೆಗೆ ಅರ್ಹವಾಗಿದೆ ಏಕೆಂದರೆ ಅಸ್ಸೇ ಸಮಸ್ಯೆಗಳು, ಗಂಭೀರ ಅನಾರೋಗ್ಯ ಮತ್ತು ಪಿಟ್ಯೂಟರಿ ರೋಗವು ವಿಭಿನ್ನ ಸಾಧ್ಯತೆಗಳಾಗಿವೆ. ನಮ್ಮ ವಿವರಣೆಯನ್ನು ನೋಡಿ ಕಡಿಮೆ ಫ್ರೀ T4 ಮಾದರಿಗಳು ಜೊತೆ ಹೋಲಿಸಿ.
ಥೈರಾಯ್ಡ್ ಪ್ರತಿಕಾಯಗಳು ವಿಭಿನ್ನ ಪ್ರಶ್ನೆಗೆ ಉತ್ತರಿಸುತ್ತವೆ: ಅವು ಸ್ವಯಂ ನಿರೋಧಕ ಥೈರಾಯ್ಡ್ ಅಪಾಯವನ್ನು ಅಂದಾಜು ಮಾಡುತ್ತವೆ, ಇಂದಿನ ಆಯಾಸವು ಥೈರಾಯ್ಡ್ ಹಾರ್ಮೋನ್ ಕೊರತೆಯಿಂದ ಉಂಟಾಗಿದೆಯೇ ಎಂದು ಅಲ್ಲ. TSH ಮತ್ತು ಫ್ರೀ T4 ಸಾಮಾನ್ಯವಾಗಿದ್ದಾಗ ಧನಾತ್ಮಕ TPO ಪ್ರತಿಕಾಯವು ಸಾಮಾನ್ಯವಾಗಿ ಚಿಕಿತ್ಸೆಗಿಂತ ಹೆಚ್ಚಾಗಿ ನಿಯಮಿತ ಮೇಲ್ವಿಚಾರಣೆಯನ್ನು ಸೂಚಿಸುತ್ತದೆ. ಇದು ಲ್ಯಾಬ್ ಮೌಲ್ಯದ ಪಕ್ಕದಲ್ಲಿರುವ ನಕ್ಷತ್ರ ಚಿಹ್ನೆಗಿಂತ ಸಂದರ್ಭವು ಹೆಚ್ಚು ಮುಖ್ಯವಾದ ಪ್ರದೇಶಗಳಲ್ಲಿ ಒಂದಾಗಿದೆ.
B12, ಫೋಲೇಟ್ ಮತ್ತು ಸಾಮಾನ್ಯ CBC ಯ ಆಚೆಗಿನ ಸುಳಿವುಗಳು
ವಿಟಮಿನ್ B12 ಗಿಂತ ಕಡಿಮೆ 200 pg/mL (148 pmol/L) ಸಾಮಾನ್ಯವಾಗಿ ಕೊರತೆಯೆಂದು ಪರಿಗಣಿಸಲಾಗುತ್ತದೆ, ಆದರೆ 200-350 pg/mL ಒಂದು ಅನಿರ್ದಿಷ್ಟ ವ್ಯಾಪ್ತಿಯಾಗಿದ್ದು, ಅಲ್ಲಿ ಮಿಥೈಲ್ಮಲೋನಿಕ್ ಆಮ್ಲ ಅಥವಾ ಹೋಮೋಸಿಸ್ಟೈನ್ ಸಹಾಯ ಮಾಡಬಹುದು. B12-ಸಂಬಂಧಿತ ಕಡಿಮೆ ಪ್ರೇರಣೆಯು ಹೆಚ್ಚಾಗಿ ಮೆದುಳಿನ ಮಂಜು, ನಾಲಿಗೆ ನೋವು, ಜುಮ್ಮೆನಿಸುವಿಕೆ, ಸಮತೋಲನ ಬದಲಾವಣೆ ಅಥವಾ ನೆನಪುಕ illತೆ ತೊಂದರೆಯೊಂದಿಗೆ ಬರುತ್ತದೆ, ಆದರೆ ಯಾವಾಗಲೂ ರಕ್ತಹೀನತೆಯೊಂದಿಗೆ ಅಲ್ಲ.
ಅಧಿಕ MCV B12 ಅಥವಾ ಫೋಲೇಟ್ ಕೊರತೆ, ಆಲ್ಕೋಹಾಲ್ ಮಾನ್ಯತೆ, ಯಕೃತ್ತಿನ ಕಾಯಿಲೆ, ಹೈಪೋಥೈರಾಯಡಿಸಂ ಅಥವಾ ಔಷಧಗಳ ಪರಿಣಾಮಗಳನ್ನು ಸೂಚಿಸಬಹುದು, ಆದರೆ ಸಾಮಾನ್ಯ MCV ಆರಂಭಿಕ B12 ಕೊರತೆಯನ್ನು ಹೊರತುಪಡಿಸುವುದಿಲ್ಲ. ಡೆವಲಿಯಾ ಮತ್ತು ಸಹೋದ್ಯೋಗಿಗಳ ಬ್ರಿಟಿಷ್ ಮಾರ್ಗದರ್ಶಿ, ಸೀರಮ್ B12 ರೋಗಿಯ ಸ್ಥಿತಿಯೊಂದಿಗೆ ಹೊಂದಿಕೆಯಾಗದಿದ್ದಾಗ (Devalia et al., 2014) ಕ್ಲಿನಿಕಲ್ ಸಂಬಂಧ ಮತ್ತು ಎರಡನೇ ಹಂತದ ಚಯಾಪಚಯ ಗುರುತುಗಳನ್ನು ಶಿಫಾರಸು ಮಾಡುತ್ತದೆ. B12 ವಿರುದ್ಧ ಫೋಲೇಟ್ ಮಾರ್ಗದರ್ಶಿಯಲ್ಲಿ ವಿವರಿಸಲಾಗಿದೆ ಇದನ್ನು ಹೆಚ್ಚು ವಿವರವಾಗಿ ಒಳಗೊಂಡಿದೆ.
ಫೋಲೇಟ್ ರಕ್ತಹೀನತೆಯನ್ನು ಸರಿಪಡಿಸಬಹುದು ಆದರೆ B12-ಸಂಬಂಧಿತ ನರಗಳ ಹಾನಿ ಮುಂದುವರಿಯುತ್ತದೆ, ಅದಕ್ಕಾಗಿಯೇ B12 ಅನ್ನು ಪರೀಕ್ಷಿಸುವ ಮೊದಲು ಅಧಿಕ ಪ್ರಮಾಣದ ಫೋಲಿಕ್ ಆಮ್ಲದೊಂದಿಗೆ ಸ್ವಯಂ-ಚಿಕಿತ್ಸೆ ಮಾಡುವುದು ಬುದ್ಧಿವಂತಿಕೆಯಲ್ಲ. 3 ng/mL ಗಿಂತ ಕಡಿಮೆ ಸೀರಮ್ ಫೋಲೇಟ್ ಸಾಮಾನ್ಯವಾಗಿ ಕೊರತೆಯನ್ನು ಸೂಚಿಸುತ್ತದೆ, ಆದರೂ ಪ್ರಯೋಗಾಲಯದ ವಿಧಾನಗಳು ಬದಲಾಗುತ್ತವೆ. ಮೆಟ್ಫಾರ್ಮಿನ್, ಪ್ರೋಟಾನ್-ಪಂಪ್ ಇನ್ಹಿಬಿಟರ್‌ಗಳು, ಸಸ್ಯಾಹಾರಿ ಆಹಾರಗಳು, ಕರುಳಿನ ಶಸ್ತ್ರಚಿಕಿತ್ಸೆ ಮತ್ತು ಪೆರ್ನಿಷಿಯಸ್ ರಕ್ತಹೀನತೆಗಳು ಹೆಚ್ಚು ಎಚ್ಚರಿಕೆಯಿಂದ ಪರೀಕ್ಷಿಸಲು ಸಾಮಾನ್ಯ ಕಾರಣಗಳಾಗಿವೆ.
Kantesti AI B12, ಫೋಲೇಟ್, MCV, ಹಿಮೋಗ್ಲೋಬಿನ್ ಮತ್ತು ಔಷಧಿಗಳ ಇತಿಹಾಸದ ಸಂಯೋಜನೆಯನ್ನು ಹೈಲೈಟ್ ಮಾಡುತ್ತದೆ ಏಕೆಂದರೆ ಪ್ರತ್ಯೇಕ B12 ಫಲಿತಾಂಶವು ತಪ್ಪುದಾರಿಗೆಳೆಯಬಹುದು. ಹೊಸ ಜುಮ್ಮೆನಿಸುವಿಕೆ, ನಡೆಯುವ ಅಸಮತೋಲನ, ಗಮನಾರ್ಹ ನೆನಪು ಬದಲಾವಣೆ ಅಥವಾ ದೌರ್ಬಲ್ಯವು ಪೂರಕ-ಮಾತ್ರ ಪ್ರಯೋಗಕ್ಕಿಂತ ಶೀಘ್ರ ವೈದ್ಯಕೀಯ ವಿಮರ್ಶೆಯನ್ನು ಬಯಸುತ್ತದೆ.
ಗ್ಲೂಕೋಸ್ ಬದಲಾವಣೆಗಳು ಶಕ್ತಿ ಮತ್ತು ಅನುಸರಣೆಯ ಮೇಲೆ ಪರಿಣಾಮ ಬೀರಬಹುದು
ಉಪವಾಸ ಗ್ಲೂಕೋಸ್ 100-125 mg/dL (5.6-6.9 mmol/L) ಅಥವಾ HbA1c 5.7-6.4% ಪ್ರಿಡಯಾಬಿಟಿಸ್ ಅನ್ನು ಸೂಚಿಸುತ್ತದೆ, ಆದರೆ ಮಧುಮೇಹಕ್ಕೆ ಸಾಮಾನ್ಯವಾಗಿ ರೋಗಲಕ್ಷಣಗಳಿಲ್ಲದಿದ್ದಾಗ ಪುನರಾವರ್ತಿತ ದೃಢೀಕರಣದಲ್ಲಿ 6.5% ಅಥವಾ ಹೆಚ್ಚಿನ HbA1c ಅಗತ್ಯವಿರುತ್ತದೆ. ಗ್ಲೂಕೋಸ್ ಅಸ್ವಸ್ಥತೆ ಶಕ್ತಿಯ ಇಳಿಕೆ ಮತ್ತು ಕಡಿಮೆ ಏಕಾಗ್ರತೆಗೆ ಕಾರಣವಾಗಬಹುದು, ಆದರೆ ಇದು ಕಡಿಮೆ ಪ್ರೇರಣೆಗೆ ಸಾಬೀತಾದ ಸ್ವತಂತ್ರ ವಿವರಣೆಯಲ್ಲ.
HbA1c ಸುಮಾರು 8-12 ವಾರಗಳ ಸರಾಸರಿ ಗ್ಲೂಕೋಸ್ ಮಾನ್ಯತೆಯನ್ನು ಪ್ರತಿಬಿಂಬಿಸುತ್ತದೆ, ಆದರೆ ಉಪವಾಸ ಗ್ಲೂಕೋಸ್ ಒಂದು ಬೆಳಗಿನ ಏಕ ಚಿತ್ರಣವಾಗಿದೆ. ಅಮೇರಿಕನ್ ಡಯಾಬಿಟಿಸ್ ಅಸೋಸಿಯೇಷನ್ ಉಪವಾಸ ಪ್ಲಾಸ್ಮಾ ಗ್ಲೂಕೋಸ್ 126 mg/dL ಅಥವಾ ಅದಕ್ಕಿಂತ ಹೆಚ್ಚು ಮತ್ತು HbA1c 6.5% ಅಥವಾ ಅದಕ್ಕಿಂತ ಹೆಚ್ಚು ಸೂಕ್ತವಾದ ಕ್ಲಿನಿಕಲ್ ಸೆಟ್ಟಿಂಗ್‌ನಲ್ಲಿ ದೃಢೀಕರಿಸಲ್ಪಟ್ಟಾಗ ರೋಗನಿರ್ಣಯದ ಮಿತಿಗಳ ಪಟ್ಟಿಯನ್ನು ನೀಡುತ್ತದೆ (ಅಮೇರಿಕನ್ ಡಯಾಬಿಟಿಸ್ ಅಸೋಸಿಯೇಷನ್, 2025). ನಮ್ಮ ಗ್ಲೂಕೋಸ್ ಶ್ರೇಣಿ ಮಾರ್ಗದರ್ಶಿ ಊಟದ ನಂತರದ ಪ್ರತಿಕ್ರಿಯಾತ್ಮಕ ರೋಗಲಕ್ಷಣಗಳು ಆಹಾರ-ಮತ್ತು-ರೋಗಲಕ್ಷಣದ ದಾಖಲೆಯನ್ನು ಬಯಸುತ್ತವೆ, ಇನ್ಸುಲಿನ್ ದೂಷಿ ಎಂಬ ಊಹೆಯಲ್ಲ. ನಿಜವಾದ ಹೈಪೊಗ್ಲಿಸಿಮಿಯಾ ರೋಗನಿರ್ಣಯಕ್ಕೆ ರೋಗಲಕ್ಷಣಗಳು, ದಾಖಲಿತ ಕಡಿಮೆ ಪ್ಲಾಸ್ಮಾ ಗ್ಲೂಕೋಸ್ - ಸಾಮಾನ್ಯವಾಗಿ 55 mg/dL ಗಿಂತ ಕಡಿಮೆ - ಮತ್ತು ಗ್ಲೂಕೋಸ್ ಸಾಮಾನ್ಯ ಸ್ಥಿತಿಗೆ ಬಂದಾಗ ರೋಗಲಕ್ಷಣಗಳ ಪರಿಹಾರ ಅಗತ್ಯ. ಬೆರಳಿನ-ಕಡ್ಡಿ ಮೀಟರ್‌ಗಳು ಮತ್ತು ನಿರಂತರ ಸಂವೇದಕಗಳು ಉಪಯುಕ್ತವಾಗಬಹುದು, ಆದರೆ ಊಟ ಮತ್ತು ವ್ಯಾಯಾಮದ ಸುತ್ತ ಸುಳ್ಳು ಎಚ್ಚರಿಕೆಗಳು ಸಾಮಾನ್ಯವಾಗಿದೆ.
ಊಟದ ನಂತರದ ಪ್ರತಿಕ್ರಿಯಾತ್ಮಕ ರೋಗಲಕ್ಷಣಗಳು ಆಹಾರ-ಮತ್ತು-ರೋಗಲಕ್ಷಣದ ದಾಖಲೆಯನ್ನು ಬಯಸುತ್ತವೆ, ಇನ್ಸುಲಿನ್ ದೂಷಿ ಎಂಬ ಊಹೆಯಲ್ಲ. ನಿಜವಾದ ಹೈಪೊಗ್ಲಿಸಿಮಿಯಾ ರೋಗನಿರ್ಣಯಕ್ಕೆ ರೋಗಲಕ್ಷಣಗಳು, ದಾಖಲಿತ ಕಡಿಮೆ ಪ್ಲಾಸ್ಮಾ ಗ್ಲೂಕೋಸ್ - ಸಾಮಾನ್ಯವಾಗಿ 55 mg/dL ಗಿಂತ ಕಡಿಮೆ - ಮತ್ತು ಗ್ಲೂಕೋಸ್ ಸಾಮಾನ್ಯ ಸ್ಥಿತಿಗೆ ಬಂದಾಗ ರೋಗಲಕ್ಷಣಗಳ ಪರಿಹಾರ ಅಗತ್ಯ. ಬೆರಳಿನ-ಕಡ್ಡಿ ಮೀಟರ್‌ಗಳು ಮತ್ತು ನಿರಂತರ ಸಂವೇದಕಗಳು ಉಪಯುಕ್ತವಾಗಬಹುದು, ಆದರೆ ಊಟ ಮತ್ತು ವ್ಯಾಯಾಮದ ಸುತ್ತ ಸುಳ್ಳು ಎಚ್ಚರಿಕೆಗಳು ಸಾಮಾನ್ಯವಾಗಿದೆ.
ಉಪವಾಸ ಇನ್ಸುಲಿನ್ ಮಟ್ಟವು ಕಡಿಮೆ ಚಾಲನೆಗೆ ಪ್ರಮಾಣಿತ ರೋಗನಿರ್ಣಯ ಪರೀಕ್ಷೆಯಲ್ಲ. ಇದು ಆಯ್ದ ಸಂದರ್ಭಗಳಲ್ಲಿ ಚಯಾಪಚಯ ಸಂದರ್ಭವನ್ನು ಒದಗಿಸಬಹುದು, ಆದರೂ ನಿದ್ರೆಯ ಕೊರತೆ, ಇತ್ತೀಚಿನ ವ್ಯಾಯಾಮ ಮತ್ತು ತೀವ್ರ ಅನಾರೋಗ್ಯವು ಅದನ್ನು ಗಣನೀಯವಾಗಿ ಬದಲಾಯಿಸುತ್ತದೆ. HbA1c ಸಾಮಾನ್ಯವಾಗಿದ್ದಾಗ ವೈದ್ಯರು ನಿದ್ರೆಯ ಅಪ್ನಿಯಾ, ಖಿನ್ನತೆ ಮತ್ತು ಔಷಧಗಳ ಪರಿಣಾಮಗಳನ್ನು ಸಹ ಪರಿಗಣಿಸಬೇಕು.
ನಿದ್ರೆಯ ಅಡಚಣೆಯು ಪ್ರೇರಣೆ ಮತ್ತು ಲ್ಯಾಬ್ ಫಲಿತಾಂಶಗಳು ಎರಡನ್ನೂ ಬದಲಾಯಿಸಬಹುದು
ಕಳಪೆ ನಿದ್ರೆಯು ಕಡಿಮೆ ಪ್ರೇರಣೆಯ ಸಾಮಾನ್ಯ ಕಾರಣಗಳಲ್ಲಿ ಒಂದಾಗಿದೆ, ಮತ್ತು ಇದು ತಾತ್ಕಾಲಿಕವಾಗಿ ಉಪವಾಸ ಗ್ಲೂಕೋಸ್, ಕಾರ್ಟಿಸೋಲ್ ಮತ್ತು ಉರಿಯೂತದ ಗುರುತುಗಳನ್ನು ಹೆಚ್ಚಿಸಬಹುದು. ರಕ್ತ ಪರೀಕ್ಷೆಯು ನಿದ್ರಾಹೀನತೆ, ಸಿರ್ಕಾಡಿಯನ್ ಅಡೆತಡೆ ಅಥವಾ ಅಬ್ಸ್ಟ್ರಕ್ಟಿವ್ ಸ್ಲೀಪ್ ಅಪ್ನಿಯಾವನ್ನು ನಿರ್ಣಯಿಸಲು ಸಾಧ್ಯವಿಲ್ಲ; ನಿದ್ರೆಯ ಇತಿಹಾಸ ಮತ್ತು, ಸೂಚಿಸಿದಾಗ, ಔಪಚಾರಿಕ ಮೌಲ್ಯಮಾಪನವು ಕೇಂದ್ರವಾಗಿದೆ.
ಹೆಚ್ಚಿನ ರಾತ್ರಿಗಳು 6 ಗಂಟೆಗಳಿಗಿಂತ ಕಡಿಮೆ ನಿದ್ರಿಸುವ ವಯಸ್ಕರು ವಿಟಮಿನ್ ಕೊರತೆಗೆ ಕಾರಣವಾದ ಅದೇ “ನಾನು ಪ್ರಾರಂಭಿಸಲು ಸಾಧ್ಯವಿಲ್ಲ” ಭಾವನೆಯನ್ನು ವಿವರಿಸುತ್ತಾರೆ. ಗೊರಕೆ, ಸಾಕ್ಷ್ಯ ಸಹಿತ ಉಸಿರಾಟದ ವಿರಾಮಗಳು, ಬೆಳಗಿನ ತಲೆನೋವು ಮತ್ತು ಹಗಲಿನ ನಿದ್ರೆಯು ಸಾಮಾನ್ಯ CBC ಗಿಂತ ನಿದ್ರೆಯ ಅಪ್ನಿಯಾದ ಸಂಭವನೀಯತೆಯನ್ನು ಹೆಚ್ಚಿಸುತ್ತದೆ. ನಮ್ಮ ವಿಮರ್ಶೆ ಕಳಪೆ ನಿದ್ರೆ ಮತ್ತು ಪ್ರಯೋಗಾಲಯ ಪರೀಕ್ಷೆಗಳು ಒಂದು ಸಣ್ಣ ರಾತ್ರಿಯ ನಂತರ ಏನಾಗಬಹುದು ಎಂಬುದನ್ನು ವಿವರಿಸುತ್ತದೆ.
ಬೆಳಗಿನ ಕಾರ್ಟಿಸೋಲ್ ಸಾಮಾನ್ಯ “ಒತ್ತಡ ಪರೀಕ್ಷೆ” ಅಲ್ಲ. ಅನಿರ್ದಿಷ್ಟ ತೂಕ ನಷ್ಟ, ಕಡಿಮೆ ರಕ್ತದೊತ್ತಡ, ಹೈಪರ್‌ಪಿಗ್‌ಮೆಂಟೇಶನ್, ನಿರಂತರ ವಾಂತಿ ಅಥವಾ ಕಡಿಮೆ ಸೋಡಿಯಂ ಮುಂತಾದ ರೋಗಲಕ್ಷಣಗಳ ಮಾದರಿಯು ಮೂತ್ರಜನಕಾಂಗದ ಕಾಯಿಲೆಯನ್ನು ಸೂಚಿಸಿದಾಗ - ಅಥವಾ ಎಂಡೋಕ್ರೈನಾಲಜಿಸ್ಟ್ ನಿರ್ದೇಶಿಸಿದಾಗ ಇದು ಉತ್ತಮವಾಗಿ ಬಳಸಲ್ಪಡುತ್ತದೆ. ಗೊಂದಲದ, ನಿದ್ರೆಯಿಲ್ಲದ ಬೆಳಿಗ್ಗೆ ನಂತರದ ಏಕೈಕ ಅಧಿಕ ಫಲಿತಾಂಶವು ಅಪರೂಪವಾಗಿ ಕಾರ್ಟಿಸೋಲ್ ಅಸ್ವಸ್ಥತೆಯನ್ನು ಸ್ಥಾಪಿಸುತ್ತದೆ.
Kantesti ಒಂದು AI-ಚಾಲಿತ ರಕ್ತ ಪರೀಕ್ಷೆ ವಿಶ್ಲೇಷಣಾ ಸಾಧನ ಉಪವಾಸ ಸ್ಥಿತಿ, ವ್ಯಾಯಾಮ, ಆಲ್ಕೋಹಾಲ್ ಸೇವನೆ, ಅನಾರೋಗ್ಯ ಮತ್ತು ದಿನಾಂಕಗಳಾದ್ಯಂತ ಹೋಲಿಸುವ ಮೊದಲು ನಿದ್ರೆಯನ್ನು ದಾಖಲಿಸಲು ಬಳಕೆದಾರರನ್ನು ಪ್ರೋತ್ಸಾಹಿಸುತ್ತದೆ. ಆ ಸಾಮಾನ್ಯ ಸಂದರ್ಭವು ಸಾಮಾನ್ಯವಾಗಿ ತಪ್ಪುದಾರಿಗೆಳೆಯುವ ಪ್ರವೃತ್ತಿ ಎಚ್ಚರಿಕೆಯನ್ನು ತಡೆಯುತ್ತದೆ.
ಔಷಧಿಗಳ ಪರಿಣಾಮಗಳು ಸಾಮಾನ್ಯವಾಗಿ ದಿನನಿತ್ಯದ ಲ್ಯಾಬ್‌ಗಳಲ್ಲಿ ಕಾಣಿಸುವುದಿಲ್ಲ
ಸಾಮಾನ್ಯ ರಕ್ತದ ಫಲಿತಾಂಶಗಳೊಂದಿಗೆ ಔಷಧ-ಸಂಬಂಧಿತ ಉದಾಸೀನತೆ ಅಥವಾ ನಿದ್ರಾಜನಕತೆ ಸಂಭವಿಸಬಹುದು, ಆದ್ದರಿಂದ ರಚನಾತ್ಮಕ ಔಷಧಿಗಳ ವಿಮರ್ಶೆಯು ಕಡಿಮೆ ಪ್ರೇರಣೆಯ ರಕ್ತ ಪರೀಕ್ಷೆಯಷ್ಟೇ ಮೌಲ್ಯಯುತವಾಗಿದೆ. ಸಾಮಾನ್ಯ ಕೊಡುಗೆದಾರರಲ್ಲಿ ನಿದ್ರಾಜನಕ ಆಂಟಿಹಿಸ್ಟಮೈನ್ಗಳು, ಬೆಂಜೊಡಿಯಜೆಪೈನ್ಗಳು, ಓಪಿಯಾಯ್ಡ್ಗಳು, ಕೆಲವು ಆಂಟಿಸೀಜರ್ ಔಷಧಿಗಳು, ಆಂಟಿಪ್ಸಿಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್ಚ್.
ನೀವು ಖಾಲಿಯಾಗಿರುವಿರಿ ಎಂದು ಭಾವಿಸಿದರೆ ಸೂಚಿಸಿದ ಔಷಧಿಯನ್ನು ಅ ಇದ್ದಕ್ಕಿದ್ದಂತೆ ನಿಲ್ಲಿಸಬೇಡಿ. ಬೆಂಜೊಡಿಯಜೆಪೈನ್ಗಳು, ಖಿನ್ನತೆ-ನಿರೋಧಕಗಳು, ಮಾನಸಿಕ-ನಿರೋಧಕಗಳು, ಬೀಟಾ-ಬ್ಲಾಕರ್ಗಳು ಮತ್ತು ಕಾರ್ಟಿಕೊಸ್ಟೆರಾಯ್ಡ್ಗಳು ಇದ್ದಕ್ಕಿದ್ದಂತೆ ನಿಲ್ಲಿಸಿದರೆ ಹಿಂಪಡೆಯುವಿಕೆ ಅಥವಾ ಮರುಕಳಿಸುವ ಪರಿಣಾಮಗಳನ್ನು ಉಂಟುಮಾಡಬಹುದು. ಡೋಸ್ ಸಮಯ, ಪರಸ್ಪರ ಕ್ರಿಯೆಗಳು ಮತ್ತು 2-8 ವಾರಗಳಲ್ಲಿ ಲಕ್ಷಣವು ಬದಲಾವಣೆಯಿಂದ ಪ್ರಾರಂಭವಾಗಿದೆಯೇ ಎಂದು ಔಷಧಿಯುತಜ್ಞ ಅಥವಾ ಸೂಚಕರು ಮೌಲ್ಯಮಾಪನ ಮಾಡಬಹುದು.
ಮೆಟ್ಫಾರ್ಮಿನ್ ಕ್ರಮೇಣ B12 ಹೀರಿಕೊಳ್ಳುವಿಕೆಯನ್ನು ಕಡಿಮೆ ಮಾಡುತ್ತದೆ, ಮತ್ತು ದೀರ್ಘಕಾಲದ ಪ್ರೋಟಾನ್-ಪಂಪ್ ನಿರೋಧಕಗಳ ಬಳಕೆಯು ಸೂಕ್ಷ್ಮ ವ್ಯಕ್ತಿಗಳಲ್ಲಿ ಕಡಿಮೆ B12 ಸಂಭವನೀಯತೆಯನ್ನು ಹೆಚ್ಚಿಸಬಹುದು. ಅದಕ್ಕಾಗಿಯೇ ಔಷಧಿ ಪಟ್ಟಿಯು ಅಂಚಿನಲ್ಲಿರುವ B12 ಫಲಿತಾಂಶದ ಅರ್ಥವನ್ನು ಬದಲಾಯಿಸುತ್ತದೆ. ನಮ್ಮ ಮಾರ್ಗದರ್ಶಿ ಮೆಟ್ಫಾರ್ಮಿನ್ ನಂತರದ ಪ್ರಯೋಗಾಲಯ ಮೇಲ್ವಿಚಾರಣೆ ಪ್ರಾಯೋಗಿಕ ಅನುಸರಣಾ ಚೌಕಟ್ಟನ್ನು ನೀಡುತ್ತದೆ.
ಪೂರಕಗಳು ತಟಸ್ಥವಾಗಿರುವುದಿಲ್ಲ: ಅಧಿಕ-ಡೋಸ್ ಬಯೋಟಿನ್ ಥೈರಾಯ್ಡ್ ಪರೀಕ್ಷೆಗಳನ್ನು ವಿರೂಪಗೊಳಿಸಬಹುದು, ಅತಿಯಾದ ಸತು ತಾಮ್ರದ ಕೊರತೆಗೆ ಕಾರಣವಾಗಬಹುದು, ಮತ್ತು ಉತ್ತೇಜಕ-ಒಳಗೊಂಡಿರುವ ಉತ್ಪನ್ನಗಳು ನಿದ್ರೆಯನ್ನು ಉಲ್ಬಣಗೊಳಿಸಬಹುದು. ನೇಮಕಾತಿಗೆ ಧಾರಕಗಳು ಅಥವಾ ಛಾಯಾಚಿತ್ರಗಳನ್ನು ತನ್ನಿ; ಸುರಕ್ಷಿತ ವ್ಯಾಖ್ಯಾನಕ್ಕೆ “ಒಂದು ಮಲ್ಟಿವಿಟಮಿನ್” ಸಾಕಾಗುವುದಿಲ್ಲ.
ಪರಿಶೀಲಿಸಲು ಯೋಗ್ಯವಾದ ಮೂತ್ರಪಿಂಡ, ಯಕೃತ್ತು ಮತ್ತು ಎಲೆಕ್ಟ್ರೋಲೈಟ್ ಮಾದರಿಗಳು
ಮೂತ್ರಪಿಂಡದ ಕಾರ್ಯವೈಫಲ್ಯ, ಯಕೃತ್ತಿನ ಕಾಯಿಲೆ ಮತ್ತು ಅರ್ಥಪೂರ್ಣ ಎಲೆಕ್ಟ್ರೋಲೈಟ್ ಅಸಹಜತೆಗಳು ಶಕ್ತಿ, ಗಮನ ಮತ್ತು ಪ್ರೇರಣೆಯನ್ನು ಕಡಿಮೆ ಮಾಡಬಹುದು, ಆದರೆ ಸೌಮ್ಯವಾದ ಪ್ರತ್ಯೇಕ ಅಸಹಜತೆಗಳು ಹೆಚ್ಚಾಗಿ ನಿರ್ದಿಷ್ಟವಲ್ಲ. ರೋಗಲಕ್ಷಣಗಳು ನಿರಂತರವಾಗಿದ್ದಾಗ, ಔಷಧಿಗಳು ಅಪಾಯವನ್ನು ಉಂಟುಮಾಡಿದಾಗ, ಅಥವಾ ಊತ, ವಾಕರಿಕೆ, ತುರಿಕೆ ಅಥವಾ ಮೂತ್ರ ವಿಸರ್ಜನೆಯ ಬದಲಾವಣೆಗಳಂತಹ ದೈಹಿಕ ಚಿಹ್ನೆಗಳು ಇದ್ದಾಗ ಮೂಲಭೂತ ಚಯಾಪಚಯ ಫಲಕ ಮತ್ತು ಯಕೃತ್ತಿನ ಕಿಣ್ವಗಳು ಸಮಂಜಸವಾಗಿದೆ.
135 mmol/L ಗಿಂತ ಕಡಿಮೆ ಸೋಡಿಯಂ ಹೈಪೊನಾಟ್ರೆಮಿಯಾ ಆಗಿದೆ, ಮತ್ತು 125 mmol/L ಗಿಂತ ಕಡಿಮೆ ಮೌಲ್ಯಗಳು ವಾಕರಿಕೆ, ತಲೆನೋವು, ಗೊಂದಲ ಅಥವಾ ಸೆಳೆತಕ್ಕೆ ಕಾರಣವಾಗಬಹುದು, ಇದು ಆಕ್ರಮಣದ ವೇಗವನ್ನು ಅವಲಂಬಿಸಿರುತ್ತದೆ. 3.0 mmol/L ಗಿಂತ ಕಡಿಮೆ ಅಥವಾ 6.0 mmol/L ಗಿಂತ ಹೆಚ್ಚಿನ ಪೊಟ್ಯಾಸಿಯಮ್ ಸಾಮಾನ್ಯವಾಗಿ ತುರ್ತು ವೈದ್ಯಕೀಯ ಗಮನಕ್ಕೆ ಅರ್ಹವಾಗಿದೆ, ವಿಶೇಷವಾಗಿ ದೌರ್ಬಲ್ಯ ಅಥವಾ ದಡಬಡಿತಗಳೊಂದಿಗೆ. ನಮ್ಮ ಓದಿ ಎಲೆಕ್ಟ್ರೋಲೈಟ್ ಎಚ್ಚರಿಕೆ ಮಾರ್ಗದರ್ಶಿ ರೋಗಲಕ್ಷಣ-ಆಧಾರಿತ ಟ್ರಿಯೇಜ್‌ಗಾಗಿ.
3 ತಿಂಗಳುಗಳು ಅಥವಾ ಅದಕ್ಕಿಂತ ಹೆಚ್ಚು ಕಾಲ 60 mL/min/1.73 m² ಗಿಂತ ಕಡಿಮೆ ಇರುವ eGFR ದೀರ್ಘಕಾಲದ ಮೂತ್ರಪಿಂಡ ಕಾಯಿಲೆಯನ್ನು ಸೂಚಿಸುತ್ತದೆ, ಆದಾಗ್ಯೂ ನಿರ್ಜಲೀಕರಣದ ಸಮಯದಲ್ಲಿ ಒಂದು ಕಡಿಮೆ eGFR ಅದನ್ನು ಸ್ಥಾಪಿಸುವುದಿಲ್ಲ. ALT ಮತ್ತು AST “ಪ್ರೇರಣಾ ಮಾರ್ಕರ್‌ಗಳು” ಅಲ್ಲ; ಅಸಹಜ ಮೌಲ್ಯಗಳು ಯಕೃತ್ತು, ಸ್ನಾಯು, ಆಲ್ಕೋಹಾಲ್ ಅಥವಾ ಔಷಧಿ ಸಮಸ್ಯೆಗಳನ್ನು ಸೂಚಿಸಬಹುದು, ಅದು ಪ್ರತ್ಯೇಕ ಮೌಲ್ಯಮಾಪನಕ್ಕೆ ಅರ್ಹವಾಗಿದೆ.
ಕಡಿಮೆ ಅಲ್ಬುಮಿನ್ ಉರಿಯೂತ, ಮೂತ್ರಪಿಂಡದ ನಷ್ಟ, ಯಕೃತ್ತಿನ ದುರ್ಬಲತೆ ಅಥವಾ ಅಸಮರ್ಪಕ ಸೇವನೆಯನ್ನು ಪ್ರತಿಬಿಂಬಿಸಬಹುದು, ಆದರೆ ಅಲ್ಬುಮಿನ್ ಮಾತ್ರ ಪೋಷಣೆ ಸ್ಕೋರ್ ಅಲ್ಲ. ನಾನು ಮಾದರಿಯನ್ನು ಕಂಡುಕೊಳ್ಳುತ್ತೇನೆ - ಅಲ್ಬುಮಿನ್, ಕ್ರಿಯೇಟಿನೈನ್, ಮೂತ್ರ ಪ್ರೋಟೀನ್, ಯಕೃತ್ತಿನ ಕಿಣ್ವಗಳು ಮತ್ತು ರೋಗಲಕ್ಷಣಗಳು - ಯಾವುದೇ ಒಂದೇ ಫಲಿತಾಂಶಕ್ಕಿಂತ ಹೆಚ್ಚು ಉಪಯುಕ್ತವಾಗಿದೆ.
ಉರಿಯೂತ, ಸೋಂಕು ಮತ್ತು ಇತರ ಕಡಿಮೆ ಸಾಮಾನ್ಯ ಲ್ಯಾಬ್ ಸುಳಿವುಗಳು
ಕಡಿಮೆ ಪ್ರೇರಣೆಯು ಜ್ವರ, ರಾತ್ರಿ ಬೆವರು, ಕೀಲು ಊತ, ತೂಕ ನಷ್ಟ ಅಥವಾ ನಿರಂತರ ನೋವಿನೊಂದಿಗೆ ಕಂಡುಬಂದಾಗ CRP, ESR ಮತ್ತು ಬಿಳಿ-ಕೋಶದ ಎಣಿಕೆಗಳು ಉರಿಯೂತದ ಅಥವಾ ಸಾಂಕ್ರಾಮಿಕ ರೋಗದ ಹುಡುಕಾಟವನ್ನು ಬೆಂಬಲಿಸಬಹುದು. ಈ ಪರೀಕ್ಷೆಗಳು ನಿರ್ದಿಷ್ಟವಲ್ಲ ಮತ್ತು ಸಾಮಾನ್ಯ ಒತ್ತಡಕ್ಕಾಗಿ ಮೀನುಗಾರಿಕೆ ದಂಡಯಾತ್ರೆಯಾಗಿ ಆದೇಶಿಸಬಾರದು.
10 mg/L ಗಿಂತ ಹೆಚ್ಚಿನ CRP ಸೋಂಕು, ಉರಿಯೂತದ ಕಾಯಿಲೆ, ಸ್ಥೂಲಕಾಯತೆ, ಧೂಮಪಾನ ಅಥವಾ ಇತ್ತೀಚಿನ ಜೋರಾದ ವ್ಯಾಯಾಮವನ್ನು ಪ್ರತಿಬಿಂಬಿಸಬಹುದು; ಅದು ಕಾರಣವನ್ನು ಹೆಸರಿಸುವುದಿಲ್ಲ. ESR ನಿಧಾನವಾಗಿ ಏರುತ್ತದೆ ಮತ್ತು ಅನಿಮಿಯಾ, ಗರ್ಭಧಾರಣೆ ಅಥವಾ ವಯಸ್ಸಿನ ಹೆಚ್ಚಳದೊಂದಿಗೆ ವಾರಗಳವರೆಗೆ ಹೆಚ್ಚಾಗಬಹುದು. ESR ವ್ಯಾಖ್ಯಾನ ಮಾರ್ಗದರ್ಶಿ CRP ಮತ್ತು ESR ಏಕೆ ಕೆಲವೊಮ್ಮೆ ಒಪ್ಪುವುದಿಲ್ಲ ಎಂಬುದನ್ನು ವಿವರಿಸುತ್ತದೆ.
ಉರಿಯೂತದ ಅನಿಮಿಯಾ ಕಡಿಮೆ ಸೀರಮ್ ಕಬ್ಬಿಣವನ್ನು ಸಾಮಾನ್ಯ ಅಥವಾ ಹೆಚ್ಚಿನ ಫೆರಿಟಿನ್‌ನೊಂದಿಗೆ ಉಂಟುಮಾಡಬಹುದು, ಇದು ವರ್ಗಾವಣೆ ಉತ್ಕರ್ಷಣ ಮತ್ತು CRP ಸಹಾಯ ಮಾಡುವ ಸ್ಥಳವಾಗಿದೆ. ಪುನರಾವರ್ತಿತ ಜ್ವರಗಳು, ಬೆವರಿನ ತೇವ, ಹಿಗ್ಗುತ್ತಿರುವ ದುಗ್ಧರಸ ಗ್ರಂಥಿಗಳು ಅಥವಾ 6-12 ತಿಂಗಳುಗಳಲ್ಲಿ 5% ದೇಹದ ತೂಕಕ್ಕಿಂತ ಹೆಚ್ಚಿನ ಅನಿಶ್ಚಿತ ನಷ್ಟವು ಪುನರಾವರ್ತಿತ ಮನೆ ಫಲಕಗಳ ಬದಲಿಗೆ ವೈದ್ಯರ ಮೌಲ್ಯಮಾಪನವನ್ನು ಪ್ರೇರೇಪಿಸಬೇಕು.
ಸುಳ್ಳು ಧನಾತ್ಮಕಗಳ ಮೂಲಕ ಪರೀಕ್ಷೆಯು ಹಾನಿಯನ್ನು ಉಂಟುಮಾಡಬಹುದು. ಕಡಿಮೆ ಪೂರ್ವ ಸಂಭವನೀಯತೆ ಇದ್ದಾಗ ವಿಶಾಲ ಸ್ವಯಂ ನಿರೋಧಕ ಫಲಕಗಳು ವಿಶೇಷವಾಗಿ ದುರ್ಬಲವಾಗಿರುತ್ತವೆ, ಮತ್ತು ದುರ್ಬಲವಾಗಿ ಧನಾತ್ಮಕ ಪ್ರತಿಕಾಯವು ಪ್ರೇರಣೆಯನ್ನು ವಿವರಿಸದೆ ಆತಂಕವನ್ನು ಸೃಷ್ಟಿಸಬಹುದು. ರೋಗಲಕ್ಷಣಗಳು ಮತ್ತು ಪರೀಕ್ಷೆಯ ಫಲಿತಾಂಶಗಳೊಂದಿಗೆ ಪ್ರಾರಂಭಿಸಿ, ನಂತರ ಉದ್ದೇಶಪೂರ್ವಕವಾಗಿ ಪರೀಕ್ಷಿಸಿ.
ಮಾನಸಿಕ-ಆರೋಗ್ಯ ಮೌಲ್ಯಮಾಪನವು ಅಗತ್ಯವಾದ ಮುಂದಿನ ಪರೀಕ್ಷೆಯಾದಾಗ
ಸಾಮಾನ್ಯ ಲ್ಯಾಬ್‌ಗಳು ಕಡಿಮೆ ಪ್ರೇರಣೆಯನ್ನು ಕಲ್ಪಿತವಾಗಿಸುವುದಿಲ್ಲ; ಅವು ಪ್ರಾಥಮಿಕ ಮಾನಸಿಕ-ಆರೋಗ್ಯ, ನಿದ್ರೆ ಅಥವಾ ಜೀವನ-ಸಂದರ್ಭದ ಮೌಲ್ಯಮಾಪನವನ್ನು ಹೆಚ್ಚು ಮುಖ್ಯವಾಗಿಸುತ್ತವೆ. ಖಿನ್ನತೆಯು ಸಾಮಾನ್ಯವಾಗಿ ಕನಿಷ್ಠ 2 ವಾರಗಳವರೆಗೆ ಆಸಕ್ತಿ ಅಥವಾ ಸಂತೋಷದಲ್ಲಿ ಕಡಿತವನ್ನು ಒಳಗೊಂಡಿರುತ್ತದೆ, ಆದರೆ ಆತಂಕ, ಆಘಾತ, ADHD, ದ್ವಿಧ್ರುವ-ವರ್ಣಪಟ ರೋಗ, ದುಃಖ ಮತ್ತು ಪದಾರ್ಥದ ಬಳಕೆ ವಿಭಿನ್ನವಾಗಿ ಪ್ರಸ್ತುತಪಡಿಸಬಹುದು.
ಒಬ್ಬ ವೈದ್ಯರು ಸಂತೋಷ, ದೋಷ, ನಿರಾಶೆ, ಗಮನ, ಆತುರತೆ, ಅಸಾಧಾರಣವಾಗಿ ಹೆಚ್ಚಿನ ಶಕ್ತಿಯ ಅವಧಿಗಳು ಮತ್ತು ಆತ್ಮಹತ್ಯಾ ಚಿಂತನೆಗಳ ಬಗ್ಗೆ ನೇರವಾಗಿ ಕೇಳಬೇಕು. ರಕ್ತ ಪರೀಕ್ಷೆಯು ಖಿನ್ನತೆಯನ್ನು ಸುಡುವಿಕೆಯಿಂದ ಪ್ರತ್ಯೇಕಿಸಲು ಸಾಧ್ಯವಿಲ್ಲ, ಮತ್ತು ಕಡಿಮೆ ಜೀವಸತ್ವದ ಮಟ್ಟವು ಖಿನ್ನತೆಯನ್ನು ಹೊರತುಪಡಿಸುವುದಿಲ್ಲ. ನಮ್ಮ ಮನಸ್ಥಿತಿ ಬದಲಾವಣೆಗಳ ಪ್ರಯೋಗಾಲಯ ಮಾರ್ಗದರ್ಶಿ ಪರೀಕ್ಷೆಯು ಎಲ್ಲಿ ಸಹಾಯ ಮಾಡುತ್ತದೆ ಮತ್ತು ಎಲ್ಲಿ ಅದು ನಿಲ್ಲುತ್ತದೆ ಎಂಬುದನ್ನು ವಿವರಿಸುತ್ತದೆ.
ಜನರು ಹೆಚ್ಚು ಹೆಚ್ಚು ಅಸ್ಪಷ್ಟ ಬಯೋಮಾರ್ಕರ್‌ಗಾಗಿ ಹುಡುಕುತ್ತಿರುವಾಗ ಪರಿಣಾಮಕಾರಿ ಚಿಕಿತ್ಸೆಯನ್ನು ತಿಂಗಳುಗಳವರೆಗೆ ವಿಳಂಬಗೊಳಿಸುವುದನ್ನು ನಾನು ನೋಡಿದ್ದೇನೆ. ಫಲಿತಾಂಶಗಳು ಭರವಸೆ ನೀಡುವಂತಿದ್ದರೆ ಮತ್ತು ರೋಗಲಕ್ಷಣಗಳು ಕೆಲಸ, ಸಂಬಂಧಗಳು, ಸ್ವಯಂ-ಆರೈಕೆ ಅಥವಾ ಪೋಷಣೆಯನ್ನು ಹಾನಿಗೊಳಿಸುತ್ತಿದ್ದರೆ, ಮಾನಸಿಕ ಚಿಕಿತ್ಸೆ, ಜಿಪಿ ವಿಮರ್ಶೆ ಅಥವಾ ಮನೋವೈದ್ಯಕೀಯ ಮೌಲ್ಯಮಾಪನವು ಸೂಕ್ತ ವೈದ್ಯಕೀಯ ಆರೈಕೆಯಾಗಿದೆ - ಅಂತಿಮ ಆಶ್ರಯವಲ್ಲ. ಸ್ಕ್ರೀನಿಂಗ್ ಪರಿಕರಗಳು ಸಂಭಾಷಣೆಯನ್ನು ತೆರೆಯಬಹುದು ಆದರೆ ಪೂರ್ಣ ಮೌಲ್ಯಮಾಪನವನ್ನು ಬದಲಾಯಿಸುವುದಿಲ್ಲ.
ಆತ್ಮಹತ್ಯಾ ಆಲೋಚನೆಗಳು, ಸ್ವಯಂ-ಹಾನಿಯ ಯೋಜನೆ, ಮನೋವೈದ್ಯತೆ, ತೀವ್ರ ಕಿರಿಕಿರಿ, ತಿನ್ನಲು ಅಥವಾ ಕುಡಿಯಲು ಅಸಮರ್ಥತೆ, ಅಥವಾ ಆಕಸ್ಮಿಕ ಗೊಂದಲಕ್ಕೆ ತುರ್ತು ಅದೇ ದಿನದ ಬೆಂಬಲ ಅಗತ್ಯವಿದೆ. UK ಮತ್ತು ಅನೇಕ ಇತರ ಸೆಟ್ಟಿಂಗ್‌ಗಳಲ್ಲಿ, ತುರ್ತು ಸೇವೆಗಳು, ಬಿಕ್ಕಟ್ಟು ಲೈನ್‌ಗಳು ಮತ್ತು ತುರ್ತು ಮಾನಸಿಕ-ಆರೋಗ್ಯ ತಂಡಗಳು ಸೂಕ್ತವಾಗಿವೆ; ಪ್ರಯೋಗಾಲಯದ ಫಲಿತಾಂಶಗಳಿಗಾಗಿ ಕಾಯಬೇಡಿ.
ಪ್ರೇರಣೆ ಕಡಿಮೆಯಾದಾಗ ಆಗಾಗ್ಗೆ ದಾರಿತಪ್ಪಿಸುವ ಪರೀಕ್ಷೆಗಳು
ವಿಶಾಲ ಲೈಂಗಿಕ-ಹಾರ್ಮೋನ್ ಫಲಕಗಳು, ಹಿಮ್ಮುಖ T3, ಯಾದೃಚ್ಛಿಕ ಕಾರ್ಟಿsol, ಆಹಾರ ಸೂಕ್ಷ್ಮತೆಯ ಫಲಕಗಳು ಮತ್ತು ಏಕ “ಅಡ್ರಿನಲ್ ಫೆಟಿಗ್” ಪರೀಕ್ಷೆಗಳು ಸಾಮಾನ್ಯವಾಗಿ ತೊಡಕಿಲ್ಲದ ಪ್ರಕರಣಗಳಲ್ಲಿ ಕಡಿಮೆ ಪ್ರೇರಣೆಯನ್ನು ವಿರಳವಾಗಿ ವಿವರಿಸುತ್ತವೆ. ಅವುಗಳು ವೆಚ್ಚದಾಯಕ ಅನುಸರಣೆಯನ್ನು ಉಂಟುಮಾಡುವ ಗಡಿರೇಖೆಯ ಫಲಿತಾಂಶಗಳನ್ನು ಉಂಟುಮಾಡಬಹುದು, ಆರೈಕೆಯನ್ನು ಸುಧಾರಿಸದೆ.
ಕಾರ್ಟಿಸೋಲ್ ಒಂದು ಬಲವಾದ ದೈನಂದಿನ ಲಯವನ್ನು ಅನುಸರಿಸುತ್ತದೆ, ಆದ್ದರಿಂದ ಅಪರಾಹ್ನ ಮಾಪನವು ತಜ್ಞರು ನಿರ್ದಿಷ್ಟ ಪ್ರಶ್ನೆಗೆ ಉತ್ತರಿಸದ ಹೊರತು ಸ್ವಲ್ಪ ಮೌಲ್ಯವನ್ನು ಹೊಂದಿರುತ್ತದೆ. “ಅಡ್ರಿನಲ್ ಆಯಾಸ”ಕ್ಕಾಗಿ ಮಾರುಕಟ್ಟೆ ಮಾಡುವ ಲಾಲಾರಸ ಕಾರ್ಟಿಸೋಲ್ ಕಿಟ್‌ಗಳು ಗುರುತಿಸಲ್ಪಟ್ಟ ಅಂತಃಸ್ರಾವಕ ಸ್ಥಿತಿಯನ್ನು ಪತ್ತೆಹಚ್ಚುವುದಿಲ್ಲ. ಬರ್ನ್‌ಔಟ್ ಪ್ರಯೋಗಾಲಯ ಮಾರ್ಗದರ್ಶಿ ಮಾರುಕಟ್ಟೆ-ಚಾಲಿತ ಪ್ಯಾನೆಲ್‌ಗಳಿಂದ ಉಪಯುಕ್ತ ಹೊರಗಿಡುವ ಪರೀಕ್ಷೆಗಳನ್ನು ಪ್ರತ್ಯೇಕಿಸುತ್ತದೆ.
ಕಡಿಮೆ ಕಾಮಪ್ರಚೋದನೆ, ಬೆಳಗಿನ ಶಿಶ್ನ ઉત્થાન ಕೊರತೆ, ಬಂಜೆತನ, ಕಡಿಮೆ ಮೂಳೆ ಸಾಂದ್ರತೆ ಅಥವಾ ಸ್ಪಷ್ಟ ಹೈಪೊಗೊನಾಡಲ್ ಲಕ್ಷಣಗಳೊಂದಿಗೆ ಟೆಸ್ಟೋಸ್ಟೆರಾನ್ ಸಂಬಂಧಿತವಾಗಿರಬಹುದು, ಆದರೆ ಒಂದು ಅಪರಾಹ್ನ ಫಲಿತಾಂಶವು ವಿಶ್ವಾಸಾರ್ಹವಲ್ಲ. ಪುರುಷರಲ್ಲಿ, ರೋಗನಿರ್ಣಯಕ್ಕೆ ಮೊದಲು ಪುನರಾವರ್ತಿತ ಮುಂಜಾನೆಯ ಪರೀಕ್ಷೆ ಸಾಮಾನ್ಯವಾಗಿ ಅಗತ್ಯ; ಮಹಿಳೆಯರಲ್ಲಿ, ಚಕ್ರದ ಸಮಯ ಮತ್ತು ಹಾರ್ಮೋನುಗಳ ಗರ್ಭನಿರೋಧಕ ವ್ಯಾಖ್ಯಾನವನ್ನು ಗಮನಾರ್ಹವಾಗಿ ಬದಲಾಯಿಸುತ್ತದೆ.
ವಿನ್ಯಾಸದ ಪ್ರಕಾರ ಸುಮಾರು 5% ಆರೋಗ್ಯವಂತ ಜನರಲ್ಲಿ ಉಲ್ಲೇಖದ ಅಂತರದ ಹೊರಗಿನ ಫಲಿತಾಂಶ ಕಂಡುಬರುತ್ತದೆ. ಅತ್ಯಂತ ಉಪಯುಕ್ತ ಪ್ರಶ್ನೆಯು “ಇದನ್ನು ಧ್ವಜ ಹಾಕಲಾಗಿದೆಯೇ?” ಅಲ್ಲ, ಆದರೆ “ಈ ಫಲಿತಾಂಶವು ನನ್ನ ರೋಗಲಕ್ಷಣಗಳು, ಔಷಧಿಗಳು, ಪರೀಕ್ಷೆ ಮತ್ತು ಹಿಂದಿನ ಮೌಲ್ಯಗಳಿಗೆ ಹೊಂದಿಕೆಯಾಗುತ್ತದೆಯೇ?”
ಸಾಮಾನ್ಯ ವ್ಯತ್ಯಾಸವನ್ನು ಬೆನ್ನಟ್ಟುವಾಗ ಪರೀಕ್ಷೆಗಳನ್ನು ಪುನರಾವರ್ತಿಸುವುದು ಹೇಗೆ
ಮೊದಲ ಫಲಿತಾಂಶವು ಅಂಚಿನಲ್ಲಿರುವಾಗ, ಅನಾರೋಗ್ಯದ ಸಮಯದಲ್ಲಿ ಸಂಗ್ರಹಿಸಿದಾಗ, ತಿಳಿದಿರುವ ಪೂರ್ವ-ವಿಶ್ಲೇಷಣಾತ್ಮಕ ಅಂಶದಿಂದ ಪ್ರಭಾವಿತವಾದಾಗ, ಅಥವಾ ಚಿಕಿತ್ಸೆಯ ನಂತರ ಬದಲಾಗುವ ಸಾಧ್ಯತೆ ಇದ್ದಾಗ ಪುನರಾವರ್ತಿತ ಪರೀಕ್ಷೆಯು ಹೆಚ್ಚು ಉಪಯುಕ್ತವಾಗಿದೆ. ಒಂದೇ ರೀತಿಯದನ್ನು ಹೋಲಿಸುವುದು—ಅದೇ ಪ್ರಯೋಗಾಲಯ, ದಿನದ ಸಮಯ, ಉಪವಾಸ ಸ್ಥಿತಿ ಮತ್ತು ವ್ಯಾಯಾಮದ ಮಾದರಿ—ತಪ್ಪು ಎಚ್ಚರಿಕೆಗಳನ್ನು ಕಡಿಮೆ ಮಾಡುತ್ತದೆ.
ಫೆರಿಟಿನ್ ಸಾಮಾನ್ಯವಾಗಿ ವಾರದಿಂದ ತಿಂಗಳುಗಳವರೆಗೆ ಬದಲಾಗುತ್ತದೆ, HbA1c ಸುಮಾರು 90 ದಿನಗಳಲ್ಲಿ, ಮತ್ತು ಲೆವೊಥೈರಾಕ್ಸಿನ್ ಡೋಸ್ ಹೊಂದಾಣಿಕೆಯ ನಂತರ TSH ಸಾಮಾನ್ಯವಾಗಿ 6-8 ವಾರಗಳನ್ನು ನೆಲೆಗೊಳ್ಳಲು ತೆಗೆದುಕೊಳ್ಳುತ್ತದೆ. ದೈನಂದಿನ ಅಥವಾ ಸಾಪ್ತಾಹಿಕವಾಗಿ ಮರುಪರಿಶೀಲಿಸುವುದು ಹೆಚ್ಚಾಗಿ ಶಬ್ದವನ್ನು ಸೆರೆಹಿಡಿಯುತ್ತದೆ, ಶರೀರಶಾಸ್ತ್ರವನ್ನು ಅಲ್ಲ. ನಮ್ಮ ರಕ್ತ ಪರೀಕ್ಷೆಯ ಪ್ರವೃತ್ತಿ ಮಾರ್ಗದರ್ಶಿ ಬದಲಾವಣೆಯು ಯಾವಾಗ ಅರ್ಥಪೂರ್ಣವಾಗಬಹುದು ಎಂಬುದನ್ನು ವಿವರಿಸುತ್ತದೆ.
Kantesti AI ಹಿಂದಿನ ವರದಿಗಳನ್ನು ಹೋಲಿಸಬಹುದು ಮತ್ತು ಬದಲಾವಣೆಯ ದಿಕ್ಕನ್ನು ಧ್ವಜ ಹಾಕಬಹುದು, ಆದರೆ ಕ್ಲಿನಿಕಲ್ ಪ್ರಶ್ನೆಯು ಮೊದಲು ಬರುತ್ತದೆ: ಕಬ್ಬಿಣವನ್ನು ಬದಲಾಯಿಸಲಾಗಿದೆಯೇ, ನಿದ್ರೆ ಸುಧಾರಿತವೇ, ಔಷಧವನ್ನು ಬದಲಾಯಿಸಲಾಗಿದೆಯೇ, ಅಥವಾ ವ್ಯಕ್ತಿಯು ಮೊದಲ ಡ್ರಾದಲ್ಲಿ ತೀವ್ರವಾಗಿ ಅಸ್ವಸ್ಥರಾಗಿದ್ದರೇ? ಆ ಇತಿಹಾಸವಿಲ್ಲದ ಸಂಖ್ಯೆಗಳನ್ನು ಓವರ್‌ರೀಡ್ ಮಾಡುವುದು ಸುಲಭ.
ಭೇಟಿಗಾಗಿ, ದಿನಾಂಕಗಳು, ಸಂಪೂರ್ಣ ವರದಿಗಳು, ರೋಗಲಕ್ಷಣಗಳ ಪ್ರಾರಂಭ, ಋತುಸ್ರಾವ ಅಥವಾ ಆಹಾರದ ಬದಲಾವಣೆಗಳು ಸಂಬಂಧಿತವಾಗಿದ್ದಲ್ಲಿ, ನಿದ್ರೆಯ ಟಿಪ್ಪಣಿಗಳು ಮತ್ತು ಔಷಧಿ ಪಟ್ಟಿಯನ್ನು ತರಲು. ಆ ತಯಾರಿ 10 ನಿಮಿಷಗಳ ವಿಮರ್ಶೆಯನ್ನು ನಿಜವಾಗಿಯೂ ಉಪಯುಕ್ತ ರೋಗನಿರ್ಣಯ ಸಂಭಾಷಣೆಯಾಗಿ ಪರಿವರ್ತಿಸಬಹುದು.
ನಿರಂತರ ಕಡಿಮೆ ಪ್ರೇರಣೆಗಾಗಿ ಪ್ರಾಯೋಗಿಕ ಮುಂದಿನ-ಹಂತದ ಯೋಜನೆ
2-4 ವಾರಗಳಿಗಿಂತ ಹೆಚ್ಚು ಕಾಲ ಉಳಿಯುವ ಕಡಿಮೆ ಪ್ರೇರಣೆಗಾಗಿ, ವೈದ್ಯರ ವಿಮರ್ಶೆಯನ್ನು ಕಾಯ್ದಿರಿಸಿ, ರೋಗಲಕ್ಷಣ-ಮತ್ತು-ಔಷಧಿ ಕಾಲಾನುಕ್ರಮವನ್ನು ತರಲು, ಮತ್ತು ಲಭ್ಯವಿರುವ ಪ್ರತಿ ಪರೀಕ್ಷೆಯನ್ನು ಆದೇಶಿಸುವುದಕ್ಕಿಂತ ಕೇಂದ್ರೀಕೃತ ಪ್ಯಾನೆಲ್ ಅನ್ನು ಚರ್ಚಿಸಲು. ಸಾಮಾನ್ಯ ಆರಂಭಿಕ ಸೆಟ್ CBC, ಫೆರಿಟಿನ್, ಸೂಚಿಸಿದಾಗ ಉಚಿತ T4 ಜೊತೆಗೆ TSH, B12, HbA1c ಅಥವಾ ಗ್ಲೂಕೋಸ್, ಮೂತ್ರಪಿಂಡದ ಕಾರ್ಯ, ಎಲೆಕ್ಟ್ರೋಲೈಟ್ಗಳು ಮತ್ತು ಯಕೃತ್ತಿನ ಕಿಣ್ವಗಳನ್ನು ಒಳಗೊಂಡಿದೆ.
ಮೌಲ್ಯಮಾಪನ ನಡೆಯುತ್ತಿರುವಾಗ ನಿದ್ರೆ, ನಿಯಮಿತ ಊಟ, ಹಗಲಿನ ಬೆಳಕಿಗೆ ಒಡ್ಡಿಕೊಳ್ಳುವುದು, ಸೌಮ್ಯವಾದ ಚಟುವಟಿಕೆ ಮತ್ತು ಸಾಮಾಜಿಕ ಸಂಪರ್ಕಕ್ಕೆ ಆದ್ಯತೆ ನೀಡಿ; ಈ ಕ್ರಮಗಳು ಅನೇಕ ಕಾರಣಗಳಿಗೆ ಸಹಾಯ ಮಾಡುತ್ತವೆ ಮತ್ತು ರೋಗಲಕ್ಷಣಗಳನ್ನು ಅಮಾನ್ಯಗೊಳಿಸುವುದಿಲ್ಲ. ಒಂದೇ ಬಾರಿಗೆ ಹಲವಾರು ಪೂರಕಗಳನ್ನು ಪ್ರಾರಂಭಿಸುವುದನ್ನು ತಪ್ಪಿಸಿ, ಏಕೆಂದರೆ ಅವು ಫಲಿತಾಂಶಗಳನ್ನು ಬದಲಾಯಿಸಬಹುದು ಮತ್ತು ಏನು ಸಹಾಯ ಮಾಡಿತು ಎಂದು ತಿಳಿಯಲು ಅಸಾಧ್ಯವಾಗಿಸಬಹುದು. ಡಾ. ಥಾಮಸ್ ಕ್ಲೈನ್ ಅವರ ಪ್ರಾಯೋಗಿಕ ನಿಯಮವು ಒಂದು ಬದಲಾವಣೆ, ಒಂದು ಕಾರಣ, ಒಂದು ಯೋಜಿತ ಮರು-ಮೌಲ್ಯಮಾಪನ ದಿನಾಂಕ.
Kantesti AI ವರದಿ ಸಂಘಟನೆ ಮತ್ತು ಮಾದರಿ ಗುರುತಿಸುವಿಕೆಯನ್ನು ಬೆಂಬಲಿಸುತ್ತದೆ, ಆದರೆ ವೈದ್ಯರು ಸಂಪೂರ್ಣ ಚಿತ್ರದಿಂದ ರೋಗನಿರ್ಣಯ ಮತ್ತು ಚಿಕಿತ್ಸೆ ನಿರ್ಧಾರಗಳನ್ನು ಮಾಡುತ್ತಾರೆ. ನಮ್ಮ ಕ್ಲಿನಿಕಲ್ ಕಾರ್ಯವಿಧಾನ ಮತ್ತು ಮೇಲ್ವಿಚಾರಣೆಯನ್ನು ವೈದ್ಯಕೀಯ ಮೌಲ್ಯೀಕರಣ ದಾಖಲೆಯಲ್ಲಿ, ವಿವರಿಸಲಾಗಿದೆ, AI ವ್ಯಾಖ್ಯಾನವು ತುರ್ತು ಮೌಲ್ಯಮಾಪನ ಅಥವಾ ಚಿಕಿತ್ಸಕ ಸಂಬಂಧವನ್ನು ಏಕೆ ಎಂದಿಗೂ ಬದಲಾಯಿಸಬಾರದು ಎಂಬುದನ್ನು ಒಳಗೊಂಡಂತೆ.
ಮೊದಲ ಪರೀಕ್ಷೆಗಳು ಸಾಮಾನ್ಯವಾಗಿದ್ದರೂ ಕಾರ್ಯಕ್ಷಮತೆಯು ದುರ್ಬಲವಾಗಿದ್ದರೆ, ಅದು ಕ್ಲಿನಿಕಲ್ ಸಂಭಾಷಣೆಯನ್ನು ವಿಸ್ತರಿಸಲು ಒಂದು ಕಾರಣ - ರೋಗಲಕ್ಷಣವನ್ನು ತಳ್ಳಿಹಾಕಲು ಅಲ್ಲ. ನಮ್ಮ ವೈದ್ಯಕೀಯ ಸಲಹಾ ಮಂಡಳಿ ವೈದ್ಯಕೀಯ-ನೇತೃತ್ವದ ವಿಮರ್ಶ ಮಾನದಂಡಗಳನ್ನು ಬೆಂಬಲಿಸುತ್ತದೆ, ಮತ್ತು GP, ಮಾನಸಿಕ-ಆರೋಗ್ಯ ವೃತ್ತಿಪರರು ಅಥವಾ ನಿದ್ರ ತಜ್ಞರು ಸುರಕ್ಷಿತವಾಗಿ ಮುಂದಿನ ಹಂತವನ್ನು ನಿರ್ದೇಶಿಸಬಹುದು.
ಪದೇ ಪದೇ ಕೇಳಲಾಗುವ ಪ್ರಶ್ನೆಗಳು
ನನಗೆ ಪ್ರೇರಣೆ ಕಡಿಮೆಯಾಗಿದ್ದರೆ ಯಾವ ರಕ್ತ ಪರೀಕ್ಷೆಗಳನ್ನು ಮಾಡಿಸಿಕೊಳ್ಳಲು ಕೇಳಬೇಕು?
ಕಡಿಮೆ ಪ್ರೇರಣೆಯಿಗಾಗಿ ನಡೆಸುವ ಗುರಿನಿರ್ದಿಷ್ಟ ರಕ್ತಪರೀಕ್ಷೆಯಲ್ಲಿ ಸಾಮಾನ್ಯವಾಗಿ CBC, ಫೆರಿಟಿನ್, TSH, ಥೈರಾಯ್ಡ್ ರೋಗದ ಅನುಮಾನವಿದ್ದಾಗ ಫ್ರೀ T4, ವಿಟಮಿನ್ B12, ಉಪವಾಸದ ಗ್ಲೂಕೋಸ್ ಅಥವಾ HbA1c, ಕ್ರಿಯಾಟಿನಿನ್, ಎಲೆಕ್ಟ್ರೋಲೈಟ್ಗಳು ಮತ್ತು ಯಕೃತ್ತಿನ ಎನ್ಜೈಮ್‌ಗಳು ಸೇರಿರುತ್ತವೆ. ಹಿಮೋಗ್ಲೋಬಿನ್ ಸಾಮಾನ್ಯವಾಗಿದ್ದರೂ 30 ng/mLಕ್ಕಿಂತ ಕಡಿಮೆ ಫೆರಿಟಿನ್ ಕಬ್ಬಿಣದ ಸಂಗ್ರಹಗಳು ಕಡಿಮೆಯಾಗಿರುವುದನ್ನು ಸೂಚಿಸಬಹುದು; HbA1c 5.7–6.4% ಇದ್ದರೆ ಪ್ರೀಡಯಾಬಿಟೀಸ್ ಅನ್ನು ಸೂಚಿಸುತ್ತದೆ. ನಿಖರವಾದ ಪರೀಕ್ಷಾ ಸಮೂಹವು ಲಕ್ಷಣಗಳು, ಆಹಾರ ಪದ್ಧತಿ, ಮಾಸಿಕ ಧರ್ಮದ ರಕ್ತಸ್ರಾವ, ನಿದ್ರೆ, ಔಷಧಿಗಳು ಮತ್ತು ದೈಹಿಕ ಪರೀಕ್ಷೆಯ ಆಧಾರದ ಮೇಲೆ ಇರಬೇಕು. ರಕ್ತಪರೀಕ್ಷೆಗಳಿಂದ ಖಿನ್ನತೆ ಅಥವಾ ಬರ್ನೌಟ್‌ ಅನ್ನು ನಿರ್ಣಯಿಸಲಾಗುವುದಿಲ್ಲ; ಆದ್ದರಿಂದ ಲಕ್ಷಣಗಳು ಮುಂದುವರಿದಾಗ ಮಾನಸಿಕ ಆರೋಗ್ಯದ ಮೌಲ್ಯಮಾಪನ ಅಗತ್ಯವಾಗಿರುತ್ತದೆ.
ನನ್ನ ಹಿಮೋಗ್ಲೋಬಿನ್ ಸಾಮಾನ್ಯವಾಗಿದ್ದರೂ ಕಡಿಮೆ ಕಬ್ಬಿಣಾಂಶದಿಂದ ಪ್ರೇರಣೆಯ ಕೊರತೆ ಉಂಟಾಗಬಹುದೇ?
ಹೌದು, ಕಬ್ಬಿಣದ ಸಂಗ್ರಹ ಕಡಿಮೆಯಾಗಿದ್ದರೂ ಹಿಮೋಗ್ಲೋಬಿನ್ ಸಾಮಾನ್ಯವಾಗಬಹುದು ಮತ್ತು ಇದು ಆಯಾಸ, ವ್ಯಾಯಾಮವನ್ನು ಸಹಿಸಿಕೊಳ್ಳುವಲ್ಲಿ ಅಸಮರ್ಥತೆ, ಕಾಲುಗಳ ಚಡಪಡಿಕೆ ಮತ್ತು ಕ್ರಿಯಾಶೀಲತೆ ಕಡಿಮೆಯಾಗಲು ಕಾರಣವಾಗಬಹುದು. ಸಕ್ರಿಯ ಉರಿಯೂತವಿಲ್ಲದ ವಯಸ್ಕರಲ್ಲಿ 30 ng/mL ಗಿಂತ ಕಡಿಮೆ ಫೆರಿಟಿನ್ ಸಾಮಾನ್ಯವಾಗಿ ಕಬ್ಬಿಣದ ಕೊರತೆಯನ್ನು ಬೆಂಬಲಿಸುತ್ತದೆ, ಮತ್ತು 20% ಗಿಂತ ಕಡಿಮೆ ಟ್ರಾನ್ಸ್‌ಫೆರಿನ್ ಸ್ಯಾಚುರೇಶನ್ ಇದಕ್ಕೆ ಪೂರಕ ಪುರಾವೆಯನ್ನು ಒದಗಿಸುತ್ತದೆ. ಉರಿಯೂತದ ಸಮಯದಲ್ಲಿ ಫೆರಿಟಿನ್ ತಪ್ಪಾಗಿ ಸಾಮಾನ್ಯ ಅಥವಾ ಹೆಚ್ಚಾಗಿ ಕಾಣಿಸಬಹುದು, ಆದ್ದರಿಂದ CRP ಮತ್ತು ಸಂಪೂರ್ಣ ಕಬ್ಬಿಣದ ಫಲಕ ಮುಖ್ಯವಾಗಬಹುದು. ಕಬ್ಬಿಣದ ಕೊರತೆಗೆ ಕಾರಣವನ್ನು ಗುರುತಿಸಿದ ನಂತರ ವೈದ್ಯರು ನಿರಂತರ ಕಬ್ಬಿಣದ ಚಿಕಿತ್ಸೆಯನ್ನು ಶಿಫಾರಸು ಮಾಡಬೇಕು.
ಥೈರಾಯ್ಡ್ ಸಮಸ್ಯೆಗಳು ಕಡಿಮೆ ಪ್ರೇರಣೆಗೆ ಕಾರಣವಾಗಬಹುದೇ?
ಹೈಪೋಥೈರಾಯಡಿಸಂ ಕಡಿಮೆ ಪ್ರೇರಣೆ, ನಿಧಾನವಾದ ಚಿಂತನೆ, ಆಯಾಸ, ಮಲಬದ್ಧತೆ, ಶೀತದ ಅಸಹಿಷ್ಣುತೆ ಮತ್ತು ಕಡಿಮೆ ಮನಸ್ಥಿತಿಗೆ ಕಾರಣವಾಗಬಹುದು. TSH 10 mIU/L ಕ್ಕಿಂತ ಹೆಚ್ಚಿದ್ದು, ಉಚಿತ T4 ಕಡಿಮೆಯಾಗಿದ್ದರೆ, ಅದು ಸ್ಪಷ್ಟವಾದ ಹೈಪೋಥೈರಾಯಡಿಸಂ ಅನ್ನು ಬಲವಾಗಿ ಸೂಚಿಸುತ್ತದೆ, ಆದರೂ ಉಲ್ಲೇಖಿತ ಶ್ರೇಣಿಗಳು ಪ್ರಯೋಗಾಲಯದಿಂದ ಪ್ರಯೋಗಾಲಯಕ್ಕೆ ಭಿನ್ನವಾಗಿರುತ್ತವೆ. ಸ್ವಲ್ಪ ಹೆಚ್ಚಿದ TSH ಮತ್ತು ಸಾಮಾನ್ಯ ಉಚಿತ T4 ಗೆ ತಕ್ಷಣದ ತೀರ್ಮಾನಗಳಿಗಿಂತ ಪುನರಾವರ್ತಿತ ಪರೀಕ್ಷೆ ಮತ್ತು ಕ್ಲಿನಿಕಲ್ ಸಂದರ್ಭದ ಅಗತ್ಯವಿದೆ. ಥೈರಾಯ್ಡ್ ಪರೀಕ್ಷೆ ಸಹ-ಅಸ್ತಿತ್ವದಲ್ಲಿರುವ ಖಿನ್ನತೆ, ನಿದ್ರೆಯ ಅಡಚಣೆ ಅಥವಾ ಔಷಧಿಗಳ ಪರಿಣಾಮಗಳನ್ನು ತಳ್ಳಿಹಾಕುವುದಿಲ್ಲ.
ಶಕ್ತಿ ಮತ್ತು ಪ್ರೇರಣೆಗೆ B12 ಮಟ್ಟವು ಎಷ್ಟು ಕಡಿಮೆಯಿದ್ದರೆ?
200 pg/mL ಗಿಂತ ಕಡಿಮೆ ವಿಟಮಿನ್ B12, ಇದು ಸುಮಾರು 148 pmol/L ಗೆ ಸಮನಾಗಿರುತ್ತದೆ, ಇದನ್ನು ಸಾಮಾನ್ಯವಾಗಿ ಕೊರತೆ ಎಂದು ಪರಿಗಣಿಸಲಾಗುತ್ತದೆ, ಆದರೆ 200-350 pg/mL ಒಂದು ಗಡಿರೇಖೆಯ ವ್ಯಾಪ್ತಿಯಾಗಿದೆ. ರೋಗಲಕ್ಷಣಗಳಲ್ಲಿ ಆಯಾಸ, ಕಡಿಮೆ ಪ್ರೇರಣೆ, ಅರಿವಿನ ಮಂಜು, ಜುಮ್ಮೆನಿಸುವಿಕೆ, ಬಾಯಿಯ ನೋವು ಮತ್ತು ಸಮತೋಲನ ಸಮಸ್ಯೆಗಳು ಸೇರಿವೆ, ಆದರೆ ಕೆಲವರಿಗೆ ರಕ್ತಹೀನತೆ ಇರುವುದಿಲ್ಲ. ಸೀರಮ್ B12 ಗಡಿರೇಖೆಯಲ್ಲಿದ್ದಾಗ ಮತ್ತು ರೋಗಲಕ್ಷಣಗಳು ಹೊಂದಿಕೊಂಡಾಗ ಅಂಗಾಂಶ-ಮಟ್ಟದ ಕೊರತೆಯನ್ನು ದೃಢೀಕರಿಸಲು ಮಿಥೈಲ್ ಮಲೋನಿಕ್ ಆಮ್ಲ ಸಹಾಯ ಮಾಡಬಹುದು. ಹೊಸ ಮರಗಟ್ಟುವಿಕೆ, ದೌರ್ಬಲ್ಯ ಅಥವಾ ನಡೆಯುವ ತೊಂದರೆಗಳನ್ನು ತಕ್ಷಣವೇ ವೈದ್ಯರಿಂದ ಮೌಲ್ಯಮಾಪನ ಮಾಡಬೇಕು.
ಕಡಿಮೆ ಪ್ರೇರಣೆಗೆ ಕಾರ್ಟಿಸೋಲ್ ಪರೀಕ್ಷೆ ಮಾಡಿಸಬೇಕೇ?
ಯಾದೃಚ್ಛಿಕ ಕಾರ್ಟಿಸೋಲ್ ಪರೀಕ್ಷೆಯು ಸಾಮಾನ್ಯವಾಗಿ ಕಡಿಮೆ ಪ್ರೇರಣೆಗೆ ಮಾತ್ರ ಉಪಯುಕ್ತವಲ್ಲ ಏಕೆಂದರೆ ಕಾರ್ಟಿಸೋಲ್ ದಿನದ ಸಮಯ, ನಿದ್ರೆ, ಅನಾರೋಗ್ಯ ಮತ್ತು ತೀವ್ರ ಒತ್ತಡದೊಂದಿಗೆ ಗಣನೀಯವಾಗಿ ಬದಲಾಗುತ್ತದೆ. ಮುಂಜಾನೆಯ ಕಾರ್ಟಿಸೋಲ್ ಮುಖ್ಯವಾಗಿ ಅಡ್ರಿನಲ್ ಕಾಯಿಲೆ, ನಿರಂತರ ವಾಂತಿ, ಕಡಿಮೆ ರಕ್ತದೊತ್ತಡ, ವಿವರಿಸಲಾಗದ ತೂಕ ನಷ್ಟ, ಹೈಪರ್‌ಪಿಗ್‌ಮೆಂಟೇಶನ್ ಅಥವಾ ಕಡಿಮೆ ಸೋಡಿಯಂ ಮುಂತಾದ ರೋಗಲಕ್ಷಣಗಳನ್ನು ಸೂಚಿಸಿದಾಗ ಬಳಸಲಾಗುತ್ತದೆ. ಒಂದೇ ಹೆಚ್ಚಿನ ಕಾರ್ಟಿಸೋಲ್ ಮೌಲ್ಯವು ದೀರ್ಘಕಾಲದ ಒತ್ತಡ ಅಥವಾ ಕುಷಿಂಗ್ ಸಿಂಡ್ರೋಮ್ ಅನ್ನು ಪತ್ತೆಹಚ್ಚುವುದಿಲ್ಲ. ವೈದ್ಯಕೀಯ-ನಿರ್ದೇಶಿತ ಪರೀಕ್ಷೆಯು ವಾಣಿಜ್ಯ “ಅಡ್ರಿನಲ್ ಆಯಾಸ” ಪ್ಯಾನೆಲ್‌ಗಳಿಗಿಂತ ಹೆಚ್ಚು ನಿಖರವಾಗಿದೆ.
ಸಾಮಾನ್ಯ ರಕ್ತ ಪರೀಕ್ಷೆಗಳು ಖಿನ್ನತೆಯನ್ನು ಸೂಚಿಸುವುದಿಲ್ಲವೇ?
ಹೌದು, ಸಾಮಾನ್ಯ ಪ್ರಯೋಗಾಲಯದ ಫಲಿತಾಂಶಗಳು ಖಿನ್ನತೆ, ಆತಂಕ, ಎಡಿಎಚ್‌ಡಿ, ಆಘಾತ-ಸಂಬಂಧಿತ ರೋಗಲಕ್ಷಣಗಳು, ದುಃಖ, ನಿದ್ರಾಹೀನತೆ ಅಥವಾ ಕಡಿಮೆ ಪ್ರೇರಣೆಗೆ ಸಂಬಂಧಿಸಿದ ಕಾರಣಗಳನ್ನು ತಳ್ಳಿಹಾಕುವುದಿಲ್ಲ. ಖಿನ್ನತೆಯನ್ನು ಕನಿಷ್ಠ 2 ವಾರಗಳ ಕಾಲ ಕಡಿಮೆ ಮನಸ್ಥಿತಿ ಅಥವಾ ಆಸಕ್ತಿಯ ನಷ್ಟ, ದೈನಂದಿನ ಕಾರ್ಯನಿರ್ವಹಣೆಯ ಮೇಲೆ ಪರಿಣಾಮ ಮತ್ತು ಸುರಕ್ಷತಾ ಪ್ರಶ್ನೆಗಳಂತಹ ರೋಗಲಕ್ಷಣಗಳಿಂದ ವೈದ್ಯಕೀಯವಾಗಿ ನಿರ್ಣಯಿಸಲಾಗುತ್ತದೆ. ಪರೀಕ್ಷೆಗಳು ಖಿನ್ನತೆಯನ್ನು ಹೋಲುವ ಅಥವಾ ಉಲ್ಬಣಗೊಳಿಸುವ ವೈದ್ಯಕೀಯ ಪರಿಸ್ಥಿತಿಗಳನ್ನು ಗುರುತಿಸಬಹುದು, ಆದರೆ ರೋಗಲಕ್ಷಣಗಳು ಮಾನಸಿಕವಾಗಿವೆ ಎಂದು ಅವು ಸಾಬೀತುಪಡಿಸಲಾರವು. ಆತ್ಮಹತ್ಯಾ ಆಲೋಚನೆಗಳು, ಮನೋವೈಕಲ್ಯ ಅಥವಾ ನಿಮ್ಮನ್ನು ನೋಡಿಕೊಳ್ಳಲು ಅಸಮರ್ಥತೆಯು ರಕ್ತ-ಪರೀಕ್ಷೆಯ ಫಲಿತಾಂಶಗಳ ಹೊರತಾಗಿಯೂ ತಕ್ಷಣದ ಸಹಾಯದ ಅಗತ್ಯವಿದೆ.
ಇಂದು AI-ಸಕ್ರಿಯ ರಕ್ತ ಪರೀಕ್ಷೆ ವಿಶ್ಲೇಷಣೆಯನ್ನು ಪಡೆಯಿರಿ
ತಕ್ಷಣದ, ನಿಖರವಾದ ಲ್ಯಾಬ್ ಪರೀಕ್ಷಾ ವಿಶ್ಲೇಷಣೆಗೆ Kantesti ಅನ್ನು ನಂಬುವ ವಿಶ್ವದಾದ್ಯಂತ 2 ಮಿಲಿಯನ್‌ಗಿಂತ ಹೆಚ್ಚು ಬಳಕೆದಾರರಿಗೆ ಸೇರಿ. ನಿಮ್ಮ ರಕ್ತ ಪರೀಕ್ಷೆ ಫಲಿತಾಂಶಗಳನ್ನು ಅಪ್‌ಲೋಡ್ ಮಾಡಿ ಮತ್ತು ಕೆಲವೇ ಸೆಕೆಂಡುಗಳಲ್ಲಿ 15,000+ ಬಯೋಮಾರ್ಕರ್‌ಗಳ ಸಮಗ್ರ ಅರ್ಥೈಸಿಕೆಯನ್ನು ಪಡೆಯಿರಿ.
📚 ಉಲ್ಲೇಖಿತ ಸಂಶೋಧನಾ ಪ್ರಕಟಣೆಗಳು
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). ಕ್ಲಿನಿಕಲ್ ವ್ಯಾಲಿಡೇಶನ್ ಫ್ರೇಮ್‌ವರ್ಕ್ v2.0 (ಮೆಡಿಕಲ್ ವ್ಯಾಲಿಡೇಶನ್ ಪೇಜ್). Zenodo. DOI: 10.5281/zenodo.17993721. ResearchGate: https://www.researchgate.net/ Academia.edu: https://www.academia.edu/. Kantesti AI ವೈದ್ಯಕೀಯ ಸಂಶೋಧನೆ.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). AI ರಕ್ತ ಪರೀಕ್ಷೆ ವಿಶ್ಲೇಷಕ: 2.5M ಪರೀಕ್ಷೆಗಳು ವಿಶ್ಲೇಷಿಸಲ್ಪಟ್ಟಿವೆ | ಜಾಗತಿಕ ಆರೋಗ್ಯ ವರದಿ 2026. Zenodo. DOI: 10.5281/zenodo.18175532. ResearchGate: https://www.researchgate.net/ Academia.edu: https://www.academia.edu/. Kantesti AI ವೈದ್ಯಕೀಯ ಸಂಶೋಧನೆ.
📖 ಬಾಹ್ಯ ವೈದ್ಯಕೀಯ ಉಲ್ಲೇಖಗಳು
NICE (2023). ಥೈರಾಯ್ಡ್ ರೋಗ: ಮೌಲ್ಯಮಾಪನ ಮತ್ತು ನಿರ್ವಹಣೆ. NICE Guideline NG145.
ಅಮೆರಿಕನ್ ಡಯಾಬಿಟೀಸ್ ಅಸೋಸಿಯೇಷನ್ ಪ್ರೊಫೆಷನಲ್ ಪ್ರಾಕ್ಟೀಸ್ ಕಮಿಟಿ (2025). ಡಯಾಬಿಟೀಸ್‌ನ ರೋಗನಿರ್ಣಯ ಮತ್ತು ವರ್ಗೀಕರಣ: ಡಯಾಬಿಟೀಸ್ ಕೇರ್—2025. ಡಯಾಬಿಟೀಸ್ ಕೇರ್.
⚕️ ವೈದ್ಯಕೀಯ ಹಕ್ಕುತ್ಯಾಗ
ಈ ಲೇಖನವು ಕೇವಲ ಶಿಕ್ಷಣ ಉದ್ದೇಶಗಳಿಗಾಗಿ이며 ವೈದ್ಯಕೀಯ ಸಲಹೆಯನ್ನು ನೀಡುವುದಿಲ್ಲ. ರೋಗನಿರ್ಣಯ ಮತ್ತು ಚಿಕಿತ್ಸೆ ನಿರ್ಧಾರಗಳಿಗಾಗಿ ಸದಾ ಅರ್ಹ ಆರೋಗ್ಯ ಸೇವಾ ಪೂರೈಕೆದಾರರನ್ನು ಸಂಪರ್ಕಿಸಿ.
E-E-A-T ವಿಶ್ವಾಸ ಸಂಕೇತಗಳು
ಅನುಭವ
ಲ್ಯಾಬ್ ಅರ್ಥೈಸುವ ಕಾರ್ಯಪ್ರವಾಹಗಳ ಮೇಲೆ ವೈದ್ಯರಿಂದ ನೇತೃತ್ವದ ಕ್ಲಿನಿಕಲ್ ವಿಮರ್ಶೆ.
ಪರಿಣಿತಿ
ಕ್ಲಿನಿಕಲ್ ಸಂದರ್ಭದಲ್ಲಿನ ಬಯೋಮಾರ್ಕರ್‌ಗಳು ಹೇಗೆ ವರ್ತಿಸುತ್ತವೆ ಎಂಬುದರ ಮೇಲೆ ಪ್ರಯೋಗಾಲಯ ವೈದ್ಯಕೀಯದ ಕೇಂದ್ರೀಕರಣ.
ಅಧಿಕಾರಯುತತೆ
ಡಾ. ಥಾಮಸ್ ಕ್ಲೈನ್ ಬರಹ; ಡಾ. ಸಾರಾ ಮಿಚೆಲ್ ಮತ್ತು ಪ್ರೊ. ಡಾ. ಹಾನ್ಸ್ ವೆಬರ್ ಅವರ ವಿಮರ್ಶೆಯೊಂದಿಗೆ.
ವಿಶ್ವಾಸಾರ್ಹತೆ
ಎಚ್ಚರಿಕೆಯನ್ನು ಕಡಿಮೆ ಮಾಡಲು ಸ್ಪಷ್ಟವಾದ ಮುಂದಿನ ಹಂತಗಳೊಂದಿಗೆ ಸಾಕ್ಷ್ಯಾಧಾರಿತ ಅರ್ಥೈಸಿಕೆ.